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1CHAPTER 1: INTRODUCTION
Approximately 1.4 million cases of human salmonellosis occur in the United
States each year. The most common causes of this disease are Salmonella enterica
serovars Typhimurium and Enteritidis. In humans, the primary source of infection is
contaminated animal food products. While this disease is primarily self-limiting, there
are many instances in which antibiotics are used for treatment; the current drug of choice
is ciprofloxacin (CDC, 2005). Recent outbreaks of multi-drug resistant Salmonella
infections in humans has led to an increasing concern about the use of antimicrobial
agents in food animals (Hsueh et al, 2004; Zansky et al, 2002).
The use of antimicrobial agents in food animals for growth promotion and
therapeutic purposes is believed to lead to emergence of resistant bacteria (Fox, 2001;
Furuya et al, 2006; Mlot, 2001). Of particular concern is the use of antimicrobial agents
in food animals leading to resistant bacterial infections in humans, especially those
caused by Escherichia coli, Campylobacter spp. and Salmonella spp. (Angulo et al, 2004;
Molbak, 2005). Consequently, use of antibiotics in food animals has been greatly
restricted, particularly the use of fluoroquinolones, such as ciprofloxacin. Indeed, current
strategies employed to reduce the emergence of resistance include a prohibition against
using the same antibacterial agent in both food animals and human patients. Thus,
resistance that develops against a particular antibacterial agent administered to a food
animal is believed to be unlikely to limit therapy of a human patient using another
antibacterial agent. For example, as ciprofloxacin is the treatment of choice for food-
borne salmonellosis in humans, it is not available for use in food animal medicine.
2However, the assumption that resistance to one specific agent does not affect
development of resistance to another drug may not be true. Recent discovery of a
multiple antibiotic resistance (mar) locus chromosomally located in Salmonella species
has complicated the issue. The mar locus responds to exposure to many classes of
antimicrobial agents and disinfectants by increasing efflux protein expression and
decreasing porin expression, leading to multi-drug resistance (Randall et al, 1997 and
2002; Sulavik et al, 1997). The increase in efflux protein expression has been found to
increase resistance to fluoroquinolones (Chu et al, 2005; Goldman et al, 1996). This
means that exposure to many different types of antimicrobials other than
fluoroquinolones can lead to fluoroquinolone-resistant salmonellosis in humans. In fact,
chloramphenicol and tetracycline have been found to induce the mar system in E. coli
and increase resistance to nalidixic acid in vitro (Cohen et al, 1989). Nalidixic acid is a
quinolone antibacterial agent closely related to the fluoroquinolones.
Discovery of the mar system in Salmonella may necessitate a change in the use of
antimicrobial agents in food animals. Tetracyclines, for example, are commonly used in
cattle, for both prophylactic and metaphylactic purposes. The assumption that use of
tetracyclines in cattle will not promote emergence of fluoroquinolone resistance in human
consumers may be incorrect. If exposure to oxytetracycline induces the expression of
multi-drug resistance mechanisms, such as the mar system, the bacteria expressing these
systems will survive exposure to moderate concentrations of oxytetracycline and are
more likely to represent a higher proportion of the bacterial population contaminating
beef products. These bacteria can then be transferred to human consumers, where they
will be resistant to not only tetracyclines but also to other antibacterial agents, including
3ciprofloxacin. Clearly, there is much research that needs to be conducted to more fully
understand the impact of the mar system in vivo, including the possibility that the use of
drugs like tetracyclines in beef cattle can lead to ciprofloxacin-resistant Salmonella
infections in humans.
4CHAPTER 2: LITERATURE REVIEW
Multiple Drug Resistance (MDR)
Definition of multiple drug resistance (MDR)
Bacteria have many ways of resisting the effects of antibiotics or other types of
chemicals commonly used to kill them. In the last ten years, research on bacterial
resistance has found that many bacteria, both Gram-positive and Gram-negative, employ
specific resistance mechanisms that work against many different classes of antibacterials
by decreasing the concentration of drug within the cell (De et al, 2001; Hooper, 2002;
Poole, 2001; Regelink et al, 1999). These mechanisms, termed multi-drug resistance
mechanisms, provide bacteria with resistance to not just one class of antimicrobials, but
to a wide range of different chemical classes. Emergence of these multi-drug resistance
mechanisms has necessitated the development of new agents with novel mechanisms of
action, which is becoming increasingly difficult to accomplish (Neu, 1992).
Overview of types of mechanisms of MDR
There are three main ways that bacteria become resistant to antibiotics: changes in
the target site; destruction of the drug by enzymes; or decreasing/limiting drug
concentration within the cell. Decreasing/limiting drug concentration within the cell is
the main focus of this review and usually results from drug efflux mechanisms and porin
down-regulation (Poole, 2002).
5Target Alteration:
Many drugs used against bacteria require a specific binding site on or within the
bacterium to cause death or inhibition of growth of the organism. A common mechanism
of resistance involves a mutational changing of a particular binding site resulting in
decreased or no binding affinity. This is seen commonly with rifampin, macrolides, and
beta-lactam antibiotics (Neu, 1992; Poole, 2002).
Alteration by Enzymes:
The main mechanism of resistance to beta-lactam antibiotics is the production of
beta-lactamase, an enzyme that cleaves the antibiotic rendering it inactive; this may be
either outside the bacterium or within the periplasmic space. Resistance to
aminoglycoside antibiotics is similar, but uses drug modification instead of enzymatic
cleavage. An aminoglycoside must be transported across the inner cytoplasmic
membrane of the gram-negative cell wall to reach the target site on the ribosome. The
bacterium secretes enzymes that conjugate the aminoglycoside outside the cell, thus
preventing the drug from being able to enter the cell (Neu, 1992).
Decreased Intracellular Drug Concentration Related to Efflux Pumps and Porin
Expression:
Efflux proteins conferring resistance to multiple classes of drugs were originally
identified in the mid 1980s as the P-glycoproteins, which are still studied today in drug -
resistant tumors. Since then, many homologs of the P-glycoprotein system have been
found in both Gram-positive and Gram-negative bacteria. Although most of these efflux
6systems use either the proton motive force or ATP to expel antibacterial agents, it is still
not clear that this is their intended function (Poole, 2001). Often, bacteria use the export
pumps for purposes related more to the environment in which they normally live than to
antibacterials. For example, it is thought that the efflux systems are often found in enteric
bacteria such as Salmonella and E. coli because they are used to help pump out toxic
compounds, such as bile acids, in that environment (Prouty et al, 2004). However, many
studies have found that exposure to antimicrobials effects the gene expression of these
efflux systems (Alonso et al, 2000; Kehrenberg et al, 2001; Lewis 2002).
Efflux systems are most commonly associated with tetracycline resistance, but
recently have been found to provide resistance to many other antimicrobials (Kehrenberg
et al, 2001; Poole, 2002) such as fluoroquinolones, aminoglycosides, macrolides, and
beta-lactams, as well as antiseptics and disinfectants (Alonso et al, 2000; Putman et al,
2000). Hydrophobic agents that easily pass across the outer and inner membranes of
Gram-negative bacteria are collected in the inner side of the cytoplasmic membrane and
pumped out through an outer membrane channel. (See Figure 1)
Currently, there are four known classes of efflux pumps: the major facilitator
superfamily, the small multidrug resistance family, the resistance-nodulation-cell division
family, and the multidrug and toxic compound extrusion family (Putman et al, 2000).
The major facilitator superfamily (MFS) can be divided into two groups based on
the number of transmembrane segments (TMS). The 12-TMS group has been identified
in Staphylococcus aureus, Bacillus subtilis, Lactococcus lactis, Escherichia coli,
Cornyebacterium glutamicum, many species of Mycobacterium, and may be involved in
the fluoroquinolone resistance of Streptococcus pneumoniae. Although these 12-TMS
7sequences are not identical in different bacteria, homology is shared between them. The
other group of MFS is the 14-TMS group which has been shown to increase resistance to
compounds that include, but are not limited to, quaternary ammonium compounds,
diamines, intercalating dyes and possibly chlorhexidines, proving that multidrug
resistance is not limited to systemic antibiotics, but also affects disinfectants and
antiseptics. This set of transporters has been seen in S. aureus, E. coli, B. subtilis,
Mycobacterium species and Vibrio cholerae. Again, these are not all exactly the same
proteins, but they do show homology (Putman et al, 2000).
The small multidrug resistance family (SMR) of proteins are only 107 amino
acids in length and appear to be formed in a tightly packed four-helix antiparallel bundle.
Thesmr genes are located on an integron, and therefore are widely distributed, especially
among gram-negative isolates. Staphylococcus aureus was the first bacterial species
found to have this gene. Escherichia coli, Klebsiella aerogenes, B. subtilis and several
species of Mycobacterium also appear to have smr genes (Putman et al, 2000).
The resistance-nodulation-cell division family (RND) has been associated with
many species of Gram-negative bacteria. RND transporters interact with a membrane
fusion protein and an outer membrane protein to allow drug transport across both the
inner and outer cell membranes of Gram-negative bacteria. These RND pumps have
been identified in Pseudomonas aeruginosa, E. coli, Neisseria gonorrheoeae,
Haemophilus influenzae, Burkholderia pseudomallei, and Stenotrophomonas maltophilia.
All of these pathogens have presented challenges in the therapy of human and animal
health problems due to high incidences of resistance (Alonso et al, 2000; Putman et al,
2000).
8The final family is the multidrug and toxic compound extrusion family (MATE).
Thus far, this protein has been found only in Vibrio parahaemolyticus and E. coli, but has
been shown to mediate resistance to dyes, fluoroquinolones, and aminoglycosides.
Gram-negative bacteria in general are more resistant to antimicrobials than the
Gram-positive bacteria. This is mainly attributed to the Gram-negative complex outer
membrane barrier, which is only selectively permeable. This membrane limits the access
of chemicals to the inside of the cell, the main site of action for most commonly used
antimicrobials (Ames, 1998). Gram-negative bacteria use water-filled (aqueous)
channels, termed porins, in the outer membrane for acquisition of small nutrients, amino
acids, some polar molecules and ions (De et al, 2001).
Porins were originally thought to exclude most drugs because of size restriction:
however, more recent research has found that porins may be important in allowing drug
access to the cell, particularly the hydrophilic agents that cannot diffuse across the outer
membrane (Mallea et al, 1998; Nikaido, 1993). (See Figure 1) Several studies of Gram-
negative bacteria in vitro have shown decreased porin expression in the presence of
antibiotic, signifying that regulation of porin protein expression may be an important
mechanism of resistance employed by these bacteria (Mallea et al, 1998; Regelink et al,
1999).
Studies have identified porins that allow passage of antibacterials in Enterobacter
species, Haemophilus species, and, probably, Mannheimia haemolytica. The porins
recognized have been designated Omp C and Omp F in Enterobacteriaceae species and
Omp P2 in Haemophilus species. Recent studies have identified similar proteins in M.
haemolytica.
9In the presence of antibiotics, these experiments have indicated that resistant
strains down-regulate porin proteins compared with those strains grown in the absence of
antibiotics (De et al, 2001; Mallea et al, 1998). Down-regulation of the porin proteins
appears to limit antibiotic access to the cell, resulting in resistance against many different
classes of antibiotics. So far, porin regulation has been found to provide resistance to
beta-lactams, chloramphenicols, and tetracyclines (De et al, 2001; Mallea et al, 1998).
How exactly the porins are regulated and to what extent, still remains to be seen. Current
research is focusing on learning more about porins and how they are controlled.
marRAB as a mediator of MDR
The multiple antibiotic resistance (mar) system is a chromosomally mediated
form of multidrug resistance (Barbosa et al, 2000). The genes encoded by this system are
responsible for up-regulating efflux protein systems and down-regulating porin protein
expression along with a variety of other genes. This combination of increasing efflux and
decreasing porin expression creates multi-drug resistance by decreasing intracellular
concentration of both hydrophobic (efflux) and hydrophilic (porin) chemicals, decreasing
the efficacy of a wide range of antimicrobial agents. There are five genes included in the
mar system; marO encodes the operon, marR encodes the regulator, and marA is
primarily responsible for the up and down-regulation of other proteins. The functions of
marB and marC are still unclear. Under normal conditions, in the absence of any
antimicrobials, the MarR protein represses marO, inhibiting the expression of marA, B
and C (Alekshun et al, 2000; Cohen et al, 1993a; Martin et al, 2004). In the presence of
certain antimicrobial agents, MarR becomes inhibited through binding to the agent. This
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allows marO to initiate transcription and translation of marA, B and C (Martin et al,
1996). (See Figure 1).
The MarA protein is considered to be the master regulator (Alekshun et al, 1997;
Gambino et al, 1993; Hachler et al, 1991; Jair et al, 1995). It is currently believed to up-
regulate approximately 47 genes in some bacterial strains, including efflux components,
as well as down-regulate approximately 15 genes including the porin proteins (Chollet et
al, 2002; Cohen et al, 1988; Fralick, 1996). The mar system has been found in many
different organisms, including E. coli O157:H7, Enterobacter aerogenes,Campylobacter
spp., Salmonella spp. and others (Barbosa et al, 2000; Chollet et al, 2002 and 2004;
Randall et al, 2003; Tavio et al, 2004; Yaron et al, 2003).
Compounds that are known to induce the mar system include salicylate,
acetominophen, naphthoquinones, and sodium benzoate (Alekshun et al, 1999a; Cohen et
al, 1993b; Randall et al, 2002; Seone et al, 1995). It is thought that certain antibiotics
may also induce the system in certain bacteria, but not in others. For example,
tetracycline is believed to induce mar in E. coli, but not in Salmonella (Randall et al,
2002). The expression of marA has been shown to increase resistance to a broad range of
antibiotics, including tetracyclines, fluoroquinolones, and beta-lactams (Chu et al, 2005;
Randall et al, 2002; White et al, 1997).
While the induction of the mar system is known to increase resistance to other
compounds, the change in resistance is generally smaller than the resistance resulting
from specific mutations or gene acquisitions. The current hypothesis is that mar allows
bacteria an opportunity to mutate or acquire those genes that will confer a higher level of
resistance and is therefore thought of as more of a stepping-stone to a high level of
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resistance (Alekshun et al, 1997; Goldman et al, 1996). The relevance of this system in
vivo is unknown at this time, but it is thought to be important in both human and
veterinary medicine (Randall et al, 2001).
Relevance of MDR to Human and Animal Health
The development of resistant strains of bacteria is increasing the morbidity and
mortality of bacterial diseases as well as the cost of both human and animal health care
(Shlaes et al, 1997). Emergence of these pathogens is occurring at a frightening rate, and
the development of new chemicals to combat these bacteria has not kept pace with the
emergence of resistant strains. Salmonella, Pseudomonas, Streptococcus, Enterobacter
and Staphylococcus strains are proving to be formidable enemies to hospitals and patients
(Boyce, 2001; Russell, 2002). Infections caused by these bacteria, especially strains like
methicillin-resistant S. aureus, vancomycin-resistant enterococci or fluoroquinolone-
resistant Salmonella, are almost impossible to treat due to the lack of available drugs that
are able to kill these pathogens (Boyce, 2001; Randall et al, 2004).
The largest problems are seen in humans and animals that may be
immunocompromised, which explains why most problems occur in hospital situations.
In these cases, normal flora or commensals become opportunistic pathogens and can be
lethal. These are often the strains that are extremely resistant to a wide variety of drugs
due to efflux expression or porin regulation (Boyce, 2001; FAAIR et al, 2002).
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Relevance of Exposure to Selection/Expression of Resistance
Many studies have demonstrated that exposure to antimicrobials may actually be
promoting development of resistance. It is understood that antibacterial agents do not
initiate gene mutatation to resistant genotypes but select for those isolates that become
resistant due to mutation or acquisition of resistance genes. In vitro studies demonstrate
expression or down-regulation of certain multi-drug resistance mechanisms only in the
presence of antibacterial agents (see marRAB) (De et al, 2001).
In the absence of antibacterial drugs, mechanisms such as the marRAB system
may be a hindrance to growth and therefore are not always part of the expressed genome
in these situations. Only in the presence of antibiotics do these mechanisms seem to
allow the bacteria to survive better than those strains not expressing resistance.
These findings have led many to believe that the prophylactic use of broad-
spectrum agents, especially in food animals, needs to be more tightly controlled (Levy,
1998). It appears that many of the resistant strains that cause severe problems in humans
may be closely associated with, or even the same as, those strains found in healthy food
animals that are receiving regular antibiotic treatment (Fox, 2001; Mlot, 2001). Although
blame is often directed at food animal production and antibiotic use, many researchers are
finding that any exposure to any antimicrobial at any time can lead to resistance.
Therefore, the constant and inappropriate uses of these drugs in both food animals and in
human medicine are providing opportunities for resistance to develop (Mlot, 2001).
Many steps have been taken by the FDA and the CDC to combat the emergence
of antibacterial resistance, and specific committees have been set up to educate the public
on the occurrence of resistance, the steps that can be taken to stop it, and why it is
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important (Fox, 2001; Mlot, 2001; Shlaes et al, 1997). Currently, more research is being
done to determine how these mechanisms are regulated, and to develop new methods of
killing these resistant bacteria.
Salmonella Typhimurium
Overview of the Organism
Salmonella enterica serovar Typhimurium is a Gram-negative rod of the
Enterobacteriaceae family. It is a facultative intracellular organism that utilizes carrier
animals as its primary reservoir. Salmonella is primarily an enteric pathogen that is
capable of causing infection anywhere in the body once it crosses the gastrointestinal
epithelium (Radostits et al, 2000).
Pathogenesis of Infection
Many animals are carriers of Salmonella Typhimurium and show no clinical signs
of infection. However, once these animals are stressed they may start to show clinical
signs, but just importantly they shed the organism in the feces. Other animals that are
naïve to the organism ingest it from feces-contaminated food or water. Once in the
gastrointestinal tract, Salmonella uses fimbriae for attachment and invades the
gastrointestinal epithelium, causing vacuole formation in the epithelial cells. The
immune response results in large numbers of neutrophils infiltrating the lamina propria
and lumen surface. In addition, Salmonella can release a cytotoxin that inhibits protein
synthesis in eukaryotic cells, resulting in cell death. Endotoxin from the bacterial cell
wall as well as the host cell death result in severe inflammation of the lower small
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intestine and colon resulting in secretory and/or hemorrhagic diarrhea (CDC, 2005;
Radostits et al, 2000).
Salmonella survives within macrophages by inhibiting phagolysosome fusion
(Eriksson et al, 2003). It is this adaptation that allows the organism to invade the
macrophages in the Peyer’s patches of the intestine and use this site to gain access to
other lymph nodes as well as the blood stream. Once in the blood stream, a severe
septicemia develops that can lead to infection in almost any organ or site of the body,
including the central nervous system (Radostits et al, 2000). Death is usually associated
with endotoxemia.
In addition to colonization of carrier animals, Salmonella can be found in the
environment. It is capable of replicating at temperatures between 8 and 45°C, can
survive at a pH between 4 and 8 and in the presence or absence of oxygen. Salmonella is
also extremely resistant to drying and therefore can live in the environment for several
years (Radostits et al, 2000).
Importance as a Zoonotic Pathogen
In humans, salmonellosis is a disease caused by many different isolates of
Salmonella, Typhimurium and Enteritidis being the most common serotypes. This
disease is considered zoonotic because the primary route of infection is through
contaminated food products, mainly improperly prepared eggs (Enteritidis) and meat
(Typhimurium). In the United States, it is estimated that 1.4 million cases occur
annually; of these cases, culture by the CDC confirms approximately 40,000 (CDC,
2005).
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The human disease is characterized by fever, abdominal cramps and diarrhea that
typically lasts 5-7 days. These symptoms alone do not necessarily require treatment,
however, should the disease lead to dehydration or sepsis, treatment is required.
Treatment includes fluids and antibiotics, specifically ampicillin,
trimethoprim/sulfamethoxazole or ciprofloxacin. Approximately 600 people die each
year in the United States due to salmonellosis, and these are usually the very young, old
or immunocompromised patients. In 2% of patients, Reiter’s syndrome can develop,
which is characterized by pain in the joints, eye irritation and painful urination, and can
lead to chronic arthritis (CDC, 2005).
Antibacterial Resistance in Salmonella
Salmonella Typhimurium phage type DT104 is perhaps the most recently
notorious of the Salmonella strains. This phage type was originally identified in the early
1980s in the UK. DT104 is unique due to the chromosomal regulation of resistance to
ampicillin, chloramphenicol, streptomycin, sulfonamides and tetracycline. All of the
multi-drug resistant strains isolated prior to this strain had plasmid-mediated resistance,
believed to be acquired from other organisms. In addition, in the last 10 years, the
susceptibility of DT104 to ciprofloxacin, a common antibiotic of choice for Salmonella
infections in humans, has been declining. This resistance is chromosomally encoded and
is believed to be a result of the use of fluoroquinolone antibiotics in food animals
(Threlfall, 2002).
Phage type DT104 is not the only Salmonella organism exhibiting resistant
phenotypes. In 2002, an outbreak of salmonellosis occurred in the United States due to a
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strain of Salmonella Newport that was resistant to amoxicillin/clavulanate, ampicillin,
cefoxitin, ceftiofur, cephalothin, chloramphenicol, streptomycin, sulfamethoxazol and
tetracycline, with a few of the isolates resistant to kanamycin and ceftriazone (Zansky et
al, 2002). Researchers in Germany identified 319 different strains of Salmonella enterica
causing human infection throughout 2001. The German strains were resistant to beta-
lactams, aminoglycosides, chloramphenicol, sulfonamides and tetracycline (Miko et al,
2005). In Taiwan, ciprofloxacin resistant strains of Salmonella enterica Typhimurium
(non-DT104) and Cholerasuis were found that were transmitted from pigs to humans
(Hsueh et al, 2004).
Currently, the largest concern relating to resistance of human salmonellosis is
resistance to fluoroquinolones. Fluoroquinolone antibiotics are the treatment of choice
for salmonelloses in humans, particularly the septic form of the disease. Resistance to
fluoroquinolones is believed to result from the use of fluoroquinolones in food animals
(Molbak, 2005; Furuya et al, 2006). The mechanisms for resistance to fluoroquinolones
include mutations in genes gyrA and parC, encoding synthesis of the site of action, as
well as efflux mechanisms (Chu et al, 2005; Olliver et al, 2004; Randall et al, 2004a and
2005). Salmonella Typhimurium has five different RND efflux systems, as well as four
efflux systems belonging to the MFS, MATE and ABC families (Nishino, et al, 2005).
In addition, Salmonella has a chromosomally located mar system that, as mentioned
before, affects the expression both efflux and porin systems (Sulavik et al, 1997; Okusu
et al, 1996). While it seems practical to stop the use of fluoroquinolones in food animals
to decrease the incidence of resistant infections in humans, that alone may not be enough,
as exposure to other compounds, including other antibiotics and disinfectants, may lead
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to resistance to fluoroquinolones via the mar system (Cohen et al, 1989; Randall et al,
2004b). To assess the impact of antibiotic exposure on multi-drug resistance, the
expression of genes encoding for resistance mechanisms must be well understood.
Gene Expression and Measurement
Methods for Assessing Gene Expression
Investigating bacterial responses to certain stressors, including antibacterial
agents, cannot be accomplished without first understanding the degree to which these
stressors affect gene expression. Differential gene expression may be influenced at
several functional levels, including at the transcriptome. Methods employed to study
gene transcription include the following:
Differential display using PCR
Generally, differential display using PCR is performed as follows: Two identical
bacterial inocula are cultured in broth, one as a negative standard with minimal stress, the
other with a stressor of interest, such as an antibiotic. Once the cultures have reached the
mid-log phase of growth, the RNA is extracted and then reacted with a set of arbitrary or
random primers to reverse transcribe the RNA. A second set of arbitrary primers is then
added to make short segments of cDNA. These segments are then amplified by PCR and
the products are separated on an agarose gel. The control and stressed group gel patterns
are then compared and genes that are induced or repressed can be isolated for sequencing
and identification (Handfield et al, 1999). An advantage of this technology is that it is
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simple to perform, although somewhat time consuming. The most difficult aspect of this
experimental approach is the isolation of the bacterial RNA. Isolation of enough pure,
undegraded RNA from bacteria is not a trivial task, but once this is accomplished, the
methodology is both simple and effective.
Subtractive and differential hybridization
An alternative to differential display using PCR is subtractive and differential
hybridization. The techniques are very similar in that two cultures are grown, one control
and one stressed. The total RNA is again extracted from each sample; however, in this
case, a probe is used to bind and remove contaminant rRNA. The mRNA is then used to
synthesize cDNA by reverse transcriptase. PCR amplification of the cDNA fragments
using 5’ adaptor oligonucleotides allows for biotin labeling of the control group genes at
the 5’ end. The PCR products from both the control and stress groups are denatured and
then mixed together and allowed to hybridize. The hybridized genes are then passed over
a filter that binds the biotin labeled products and removes them, leaving only the
unlabeled segments. These unlabeled segments are denatured, mixed with the labeled
segments and allowed to hybridize again and passed over filter. This process is repeated
three times to ensure that the products recovered from the filtration process are unique
sequences found only in the stressed group of bacteria (Handfield et al, 1999). This
protocol identifies genes expressed under the stressed conditionsbut not those genes that
are repressed in stress. his protocol requires a high yield of good quality mRNA, which
as stated above is difficult to obtain. This protocol is highly specific in comparison to the
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differential display, but requires further testing to investigate all changes in expression as
it assesses only those genes that are induced under stress.
In vivo expression technology (IVET)
In vivo expression technology (IVET) is used primarily to investigate genes
expressed in vivo, versus those expressed only in vitro. DNA is cleaved into fragments
using restriction endonuclease enzymes. These fragments, from the bacterial
chromosome, are inserted into E. coli DH5 plasmid with selection for ampicillin
resistance. These plasmids (suicide vectors) are then transformed into the bacterial strain
of interest, which is then inoculated into the animal model. Bacteria are then recovered
from the animal and plated on media with selective markers such as IPTG and Xgal
(Handfield et al, 1999). Colonies can then be selected based on the expression of the
gene in vivo. While this method can select for a large number of genes that may be
associated with virulence, it is quite time consuming and expensive.
Northern blot
Northern hybridization separates RNAs based on size using an agarose gel matrix.
The relative abundance of certain RNAs can be measured based on the fluorescence once
the gel is stained. To investigate a specific gene of interest, the RNA must be transferred
to a solid matrix, such as a nylon membrane. The RNA can then be screened for certain
sequences or genes of interest using labeled probes. Once the unbound probes are
removed, those RNAs containing the sequence of interest can be identified and the
abundance of that particular transcript determined (Sambrook et al, 2001).
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This protocol has been used for many years and was originally described in 1977
(Alwine et al, 1977). There are several drawbacks to this type of analysis, including the
isolation of large amounts of intact RNA needed for this type of experiment. In addition,
the buffer for the agarose gels must contain formamide, a carcinogen, to inhibit the
denaturation of the RNA during electrophoresis. The transfer of RNA from the gel to the
solid matrix can be somewhat difficult depending on the size and abundance of RNA.
While this method has been used extensively, it is time-consuming and technically
difficult compared to the newer, similar method of microarray analysis (Sambrook et al,
2001).
Gfp reporter
Green fluorescent protein (gfp) is a detection tool that can be used two different
ways to investigate gene expression. A gfp:gene construct can be made in a suicide
vector and inserted into a bacterial chromosome. The bacteria can then be subjected to
different stresses and, or cultured in vivo and the expression of that gene compared by
measuring the level of fluorescence produced. While this approach appears straight-
forward, it is actually quite difficult to create a gfp:gene construct with certain genes
(Randall et al, 2001).
The second method for using gfp is to insert the gfp randomly into the bacterial
chromosome. The fluorescence is then measured in and out of a host environment.
Those bacteria that fluoresce in vivo, but not in vitro have the gfp inserted into a gene that
is up regulated in vivo. In this way, gfp can be used to investigate many genes as opposed
to the regulation of just one gene (Handfield et al, 1999).
21
Real time reverse transcriptase PCR
Real time PCR (qPCR) utilizes fluorescent molecules to measure the number of
amplicons produced by each iteration of the PCR process, as opposed to just a final
product. There are essentially two methods for fluorescence-labeling the PCR product:
one is to use an intercalating agent, such as Sybrgreen®, which binds any double stranded
DNA product; the other is to use a labeled probe such as TaqMan® probes, molecular
beacons or scorpions (Dharmaraj, 1998).
Sybrgreen® is very sensitive, but it binds to any double stranded product, such as
primer-dimers. This method requires an extra step following completion of the PCR; a
melting curve analysis. Generating a melting curve involves heating the product until the
intercalating reagent is released. If one PCR product is present, all reactions will occur
around one time point (i.e. one peak will be visible), but if non-specific binding or
primer-dimers are present, they will melt at a different time/temperature creating more
than one peak (Applied Biosystems, 2001).
TaqMan® technology is an example of a probe reaction in which primers and a
probe are designed together. The probe has a quencher on one end and a fluorescent
molecule on the other end. The probe initially binds the specific sequence; the primers
then initiate elongation of the second strand, eventually cleaving the probe from the
primary strand. The cleavage of the probe causes an increase in fluorescence, due to
release from the quencher, that is measured at each step in the PCR cycle (Dharmaraj,
1998).
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Real time PCR can be coupled with reverse transcriptase to detect and quantitate
mRNA. Real time, reverse transcriptase PCR (RT-qPCR) is an extremely sensitive
method that can be used to quantitate changes in gene expression. The sequence
detection system first creates cDNA, which is then amplified by PCR, with detection of
each amplicon. The resulting graph describing the production of fluorescence (related to
DNA concentration) as a function of time forms a sigmoidal curve with the point of
reference in the middle of the exponential phase of replication. A threshold (Ct) value is
set once the fluorescence crosses this threshold and the cycle number is recorded and
used for data analysis. The lower the Ct value, the higher the initial amount of mRNA
template present, and the higher the level of expression of the gene of interest (Applied
Biosystems, 2001; Dharmaraj, 1998).
There are two methods used to quantitate real time analysis; the standard curve
method and the comparative Ct method. The standard curve method is constructed from
RNA of known concentrations, which involves the assembly of cDNA plasmids for each
gene of interest that are then reverse transcribed into the RNA standards and accurately
quantitated. This curve is then used to determine the concentration for mRNA from the
unknown sample. This method, while extremely accurate, is very time consuming,
especially when there is more than one gene of interest (Applied Biosystems, 2001;
Dharmaraj, 1998).
The second method of quantitation is the comparative Ct method. This compares
the Ct values of the sample of interest with a control sample, such as a non-treated
sample. The Ct values of both the sample of interest and the control must be normalized
to a housekeeping gene, which is a gene that is expressed to the same extent in both
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samples, and that has an amplification efficiency that is similar to that of the gene of
interest. In bacteria, the housekeeping gene most commonly used is 16s RNA. To
determine the amplification efficiency, the RNA is diluted to create different
concentrations and the concentrations vs. Ct values are plotted for both the gene of
interest and the housekeeping gene. The resulting plots should have similar slopes,
indicating that the efficiency is similar for the two genes. The fold difference in
expression is calculated using the equation 2-ddCt, where ddCt is equal to dCt[sample]-
dCt[reference]. In this equation, dCt[sample] is the Ct value for that sample, normalized
to the housekeeping gene for that sample, and dCt[reference] is the Ct value for the
reference normalized to the housekeeping gene for the reference (Applied Biosystems,
2001; Dharmaraj, 1998).
Microarray analysis
Microarray analysis usually involves genome wide expression analysis on a
microscope slide. The array is created by selecting genes of interest and binding them to
a microscope slide. There are several techniques for binding DNA to the slide, and
several companies now offer commercially prepared slides with complete genomes for
certain bacteria. The creation of the slide is crucial to the success of the experiment, and
if done in the lab can be very time-consuming, depending on the number of genes of
interest. For each gene, a PCR reaction must be performed to generate a large number of
sequence copies. The PCR product must then be cleaned and placed in an appropriate
buffer and an array printer is then used to transfer the PCR products to the slide (Hedge et
al, 2000).
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A large amount of RNA is required for this analysis; usually a minimum of 10-15
µg of each sample. The RNA is reverse transcribed to DNA with an amino-allyl labeled
nucleotide (usually dUTP). This reaction is cleaned to remove any unused reactants and
then the cDNA is labeled with a cyanine fluor, typically Cy3 for the control sample and
Cy5 for the treatment sample. Following labeling, the reaction product is cleaned again
and concentrated (Hedge et al, 2000; Stintzi, 2005).
Hybridization of the RNA to the array requires preparation of the slide with
prehybridization buffer as well as resuspension of the labeled cDNA in the appropriate
buffer for the slide. Once the labeled probe is applied to the array, it is allowed to
hybridize for 16 to 20 hours. The slide is then cleaned using several different buffers
containing different concentrations of phosphate buffered saline (PBS), sodium dodecyl
sulfate (SDS) and sodium chloride-sodium citratein (SSC) to remove any unbound probes
that would compromise analysis (Hedge et al, 2000).
Analysis of the slide involves scanning of the slide and image processing. There
are several software packages that can assist in identifying spots and subtracting out the
background for each spot individually, as background can vary throughout the slide.
Normalization of the data can be achieved by adding a number of controls in increasing
concentrations to both labeling reactions; the sum of these spots should be equal.
Another normalization technique involves linear regression analysis of measured
intensities of certain genes assumed to be equally expressed in the control and treated
samples. There are other normalization procedures that have been incorporated into the
software used to analyze the slide. Once the slide has been normalized, the genes that are
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differentially expressed can be identified and analyzed for the fold difference in
expression (Hedge et al, 2000).
Microarray can be used to investigate bacterial gene expression in many different
stress conditions, including exposure to antibiotics. It can also be used to compare gene
expression in vivo versus in vitro cultures. However, the large amount of RNA necessary
for the assay makes in vivo collection difficult and time-consuming. In addition, the
process of creating and hybridizing a sensitive array can be technically demanding
(Hinton et al, 2004). Nevertheless, it is becoming an increasingly popular means of
genome expression analysis and will likely become fairly common in bacterial studies.
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Figure 1. Diagram depicting both efflux pump and porin protein structures. Efflux
pumps collect hydrophobic chemicals at the inner part of the cytoplasmic membrane and
pump them out through an outer membrane channel. Porin proteins allow passage of
hydrophilic molecules into the cell.
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Figure 2. The mar regulon. Under normal conditions, MarR protein binds and inhibits
marO from expression. In the presence of antibiotic, the MarR protein
becomes bound and can no longer inhibit marO. MarO then initiates the
transcription and translation of marA, marB and marC. MarA then initiates
the transcription and translation of many other proteins including efflux and
porin systems.
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CHAPTER 3: HYPOTHESIS AND EXPERIMENTAL OBJECTIVES
The goal of this research was to evaluate the contribution of the mar regulon to
survival of Salmonella enterica serovar Typhimurium, in the absence of antibiotics or in
the presence of subtherapeutic or therapeutic levels of oxytetracyline. The underlying
hypothesis upon which this goal was based is that the prevalence of bacteria that are
antibiotic resistant due to the expression of multidrug resistance systems increases when
cattle are administered prophylactic antibiotics and that the wide substrate specificity of
these systems confers resistance not only to antibiotics used prophylactically but also to
antibiotics used therapeutically in cattle and human consumers of contaminated beef
products. To achieve this goal, experiments were organized into two phases:
Phase I
Previous studies have reported that expression of the mar system in E. coli is
affected by many different substrates, including tetracycline, but that expression of the
mar system in Salmonella may not be induced by tetracycline (Randall et al, 2002). In
the first phase, in vitro experiments were conducted to determine whether exposure of
Salmonella Typhimurium to oxytetracycline induced expression of the mar regulon. In
addition, the genome of Salmonella Typhimurium was screened to identify other genes
that might play a role in promoting survival of the bacterium in the presence of
oxytetracycline. Specific experimental objectives were to:
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(1) develop methods for studying the expression of marA in the presence and absence of
oxytetracycline;
(2) identify and measure any incubation time-dependent changes in expression of marA
in response to different concentrations of oxytetracycline; and
(3) perform a microarray analysis of the Salmonella Typhimurium genome to identify
any genes other than marA involved in survival of the bacterium in the presence of
oxytetracycline.
Phase II
The second phase was designed to investigate the effect of oxytetracycline on
marA expression in Salmonella Typhimurium in vivo, using a bovine subcutaneous tissue
chamber model. The study was conducted in cattle because contaminated beef is the
most common source of human infection. The specific objectives of this phase were to:
(1) design an effective experimental protocol for infection of tissue chambers to allow
infected tissue fluid collection and analysis of the samples using RNA isolation
and real-time PCR.
(2) use the RT-qPCR protocol designed in Phase I to identify any changes in
expression of marA in vivo in response to parental administration of
oxytetracycline at different doses; and
(3) based on the results of the microarray analysis in Phase I, investigate the roles of
additional, selected genes that may facilitate survival of Salmonella Typhimurium
in vivo, using RT-qPCR.
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CHAPTER 4: EXPRESSION OF marA IN SALMONELLA ENTERICA SEROVAR
TYPHIMURIUM EXPOSED TO OXYTETRACYCLINE IN VITRO
Introduction
Infections caused by Salmonella spp., particularly multi-drug resistant strains, are
a recurring challenge to public health (Threlfall, 2002; Zansky et al, 2002). Of particular
concern is the transmission of resistant Salmonella from food animals to human
consumers of animal food products (Hsueh et al, 2004; Angulo et al, 2004; Miko et al,
2005). Use of antibiotics in food producing animals is suspected to promote the
emergence of multi-drug resistant organisms that can lead to potentially life threatening
infections in humans (Angulo et al, 2004; Mlot, 2001; Fox, 2001). Recent human
outbreaks have been linked to Salmonella Newport and Typhimurium DT104 (Hsueh et
al, 2004; Miko et al, 2005).
Salmonella enterica serovar Typhimurium is one of several Gram-negative
bacteria that employ the chromosomally located mar regulon as a mechanism of multi-
drug resistance (Randall et al, 2001b and 2002). The mar regulon consists of 5 genes:
marR, the repressor; marO, the operator; marA, the master regulator; and marB and
marC, the functions of which have not been clearly determined. (Figure 2) Under normal
conditions (the absence of antibiotics or chemicals), marR represses marO by binding to
it and prohibiting transcription. In the presence of certain chemicals, marR becomes
bound to the chemical and cannot bind marO. This leads to transcription and translation
of marA, B and C. The MarA protein is responsible for up-regulation of approximately
50 genes and the down-regulation of approximately 15-20 genes. The genes affected
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include the acrAB efflux system (up-regulated) and the Omp porin proteins (down-
regulated) (Randall et al, 2002; Alekshun et al, 1997, 1999; Seoane et al, 1995b). Both
efflux pumps and porins are non-specific and allow transmembrane passage of a wide
variety of antibacterial agents belonging to different chemical classes. Coordinated
regulation of efflux pumps and porin expression restricts the intracellular accumulation of
antibacterial agents, which must be in sufficiently high concentrations at intracellular
sites of action to be effective. Thus, increased expression of marA creates multiple
antibiotic resistant phenotypes (Gambino et al, 1993; Nishino et al, 2006; Eaves et al,
2004; Sulavik et al, 1997; Cohen et al, 1988).
Previous studies reported that the marA gene in E. coli is sensitive to
tetracyclines, which are commonly used in the therapy and prophylaxis of cattle diseases.
Current strategies designed to retard the emergence of resistance include avoiding use of
the same antibacterial agents in food animals and humans because development of
resistance against one agent is thought not to affect development of resistance against the
other. However, if exposure to one antibacterial agent promotes emergence of multi-drug
resistance, this assumption may not be correct. Therefore, the objectives of this study
were to identify and measure any incubation time-dependent changes in expression of
marA in response to different concentrations of oxytetracycline, and perform a
microarray analysis of the Salmonella Typhimurium genome to identify any genes other
than marA that may be important in allowing the bacterium to survive in the presence of
oxytetracycline.
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Materials and Methods
Effect of oxytetracycline exposure on expression of marA in Salmonella Typhimurium
Previous studies conducted by Randall and coworkers (2002) indicated that
expression of marA in E. coli is induced by exposure to oxytetracycline, but the
responsiveness of marA in Salmonella Typhimurium had yet to be confirmed. Therefore,
a series of gene expression studies were conducted to investigate the effect of exposure to
oxytetracycline on expression of Salmonella Typhimurium marA: Initially, bacteria were
exposed to oxytetracycline concentrations at or below the MIC value, and the effect on
gene expression was compared to that produced by a positive control, salicylate.
Thereafter, the range of oxytetracycline concentrations was expanded to include
concentrations greater than the MIC. Finally, the effect of duration of exposure to
oxytetracycline (incubation time) on gene expression was studied.
Effect of oxytetracycline at concentrations  MIC versus salicylate
Taqman® primers and probes (Roche Molecular Systems, Inc., Pleasanton, CA)
were selected for the marA gene and 16s RNA (internal control) using Primer Express®
software (Applied Biosystems Inc., Foster City, CA). Salmonella enterica serovar
Typhimurium LT2 (ATCC 700720) was streaked on LB Miller (DIFCO, Becton
Dickinson Microbiology Systems, Sparks, MD) agar plates with increasing
concentrations of oxytetracycline (0, 0.01, 0.05, 0.5, 1, and 2 µg/ml) or salicylate (0, 1,10,
20, 50 and 100 µg/ml). The concentration range selected for oxytetracycline was based
on the MIC for the bacterial isolate (2 µg/ml), which was determined using a standard
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dilution method in LB Miller broth. Inoculated plates were incubated at 37°C for 20
hours and individual colonies were then selected from the plates and transferred to LB
Miller broth (DIFCO, Becton Dickinson Microbiology Systems, Sparks, MD) containing
corresponding concentrations of oxytetracycline (0, 0.01, 0.05, 0.5, 1, and 2 µg/ml) or
salicylate (0, 1, 10, 20, 50 and 100 µg/ml). Cultures were grown in broth to mid-log
phase and samples were collected for RNA extraction.
Effect of oxytetracycline at concentrations  MIC
Further studies of the effect of oxytetracycline on expression of marA investigated
the responsiveness of Salmonella Typhimurium to a wider range of oxytetracycline
concentrations, including a concentration higher than the MIC. The experimental
methods employed for culture of bacteria in oxytetracycline were identical to those
described above, except that initial culture on LB Miller plates occurred in the absence of
oxytetracycline. Individual colonies cultured on solid media were selected and
inoculated into LB Miller broth containing 0, 1, 2 and 4 µg/ml of oxytetracycline and
incubated at 37°C. Using a reference standard curve constructed by plotting the
spectrophotometric absorbance of serial dilutions of bacteria in LB Miller broth against
the concentrations of bacteria determined by spot plate counts, the mid-log growth phases
of the broth cultures were identified and samples were collected for extraction of RNA
and determination of oxytetracycline concentrations by bioassay.
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Effect of incubation time on oxytetracycline-induced expression of marA
For these experiments, bacterial colonies isolated on LB Miller plates were
inoculated into LB Miller broth containing 2 µg/ml oxytetracycline or 100 µg/ml
salicylate. Using the absorbance-CFU reference curve, samples were collected at early-,
mid- and late-log phases of growth. Samples were subjected to the following analyses:
RNA was extracted for gene expression analysis, oxytetracycline was determined by
bioassay, and MIC values were determined for a variety of antibacterial agents and
compared with those of the inoculation strain.
Assay of oxytetracycline concentration
Samples collected for determination of oxytetracycline were centrifuged and the
supernatants were subjected to microbiological assay. Briefly, Bacillus cereus (ATCC
11778) was cultured for 4 hours in Nutrient agar. A 12” x 12” glass plate was prepared
by soaking in 5% hypochlorite solution for 30 minutes, rinsing in deionized water and air
drying. It was then sterilized by wiping with 70% propanol and placed in an oven at
65°C for 15 minutes. The plate was then placed on an adjustable stage to ensure it was
level. Approximately 600 ml of Nutrient agar was inoculated with 0.5 ml of the B.
cereus culture and then poured into the leveled glass plate and allowed to solidify. Wells
were suctioned in the agar using a grid pattern. Duplicate aliquots (150 µl) of samples or
concentration standards (0, 0.1, 0.25, 0.5, 1, 2.5, 5, 10, 15, 25 µg/ml) were pipetted into
wells, the plate was refrigerated at 4°C for 1 hour and then incubated at 37°C overnight.
Following incubation, a concentration standard curve was established by plotting
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diameters of the zones of inhibition against known concentrations of oxytetracycline.
Concentrations of the samples were determined.
Extraction of RNA and measurement of marA expression
RNA extraction was performed using a modified hot phenol method (Naikare et
al, 2006; Stintzi et al, 2003). Briefly, 10 ml of broth sample was mixed immediately
after collection with 1 ml ice-cold stop solution consisting of 10% buffered phenol in
ethanol. The mixture was centrifuged at 4°C for 15 minutes at 3500g. The supernatant
was removed and the pellet was resuspended in 800 µl lysozyme solution (0.5 mg/ml
lysozyme in TE 10,1 pH 8) before addition of 80 µl 10% SDS. The solution was placed
in a 64°C water bath for 1-2 minutes, 88 µl of 1M sodium acetate was added, and the
sample was mixed. An equal volume of water-saturated phenol was then added, and the
sample was again placed in the 64°C water bath for 8 minutes. The samples were quickly
transferred to ice and then centrifuged for 30 minutes at 19,000g and 4°C. The aqueous
layer was then transferred to a tube containing an equal volume of chloroform, mixed and
then centrifuged for 15 minutes at 19,000g and 4°C. Again, the aqueous layer was
collected and mixed with 1/10 volume 3M sodium acetate, EDTA to 1 mM, and 2.5x
volumes 99% cold ethanol. The samples were then allowed to precipitate at -80°C for at
least 24 hours. Following precipitation, the samples were centrifuged for 1 hour at
19,000g and 4°C to pellet the RNA. The supernatant was removed and the pellet washed
three times with 1 ml 80% ethanol, and then placed in a speed vacuum for 20 minutes to
dry. Samples were then resuspended in 100 µl RNase free water, DNase treated and
cleaned on a Qiagen RNeasy® column. RNA was then checked for DNA by PCR,
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integrity was confirmed by agarose gel electrophoresis and extracted RNA was
quantitated using RiboGreen® RNA quantification reagent (Molecular Probes, Eugene,
Oregon).
Expression of marA was assessed by RT-qPCR using appropriate primers and
probes. Eurogentec® one-step RT-qPCR MasterMix Plus kits were used following the
supplied protocol. All the RT-qPCR reactions were performed on an ABI Prism 7700
Sequence detector. A comparative analysis was done assuming the 16s gene
(normalizing gene) was maximally expressed under all conditions. The ddCt method was
used for data analysis to determine the fold differences in levels of expression (Applied
Biosystems, 2001). Standard deviations were used to determine statistical significance
between fold differences.
Microarray analysis to identify other genes affected by exposure to oxytetracycline.
Increased synthesis of MarA protein can be expected to affect the expression of
several other genes, including those involved in synthesis of efflux and porin proteins
(Alekshun et al, 1997). In order to study those genes regulated by marA, as well as any
other genes that may be affected by oxytetracycline exposure, expression of the entire
genome was assessed by microarray analysis. A specific oligonucleotide-based
microarray (Combimatrix Custom Array®) was designed to evaluate expression of
approximately 99% (approximately 12,000 genes) of the Salmonella Typhimurium
genome. At least 40 probes per transcript were employed to interrogate the genes
generally recognized to be involved in antibiotic resistance, including the mar regulon,
and those encoding for multi-drug efflux pumps and outer membrane porins.
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Gene expression of mid-log phase bacteria cultured in 2 µg/ml oxytetracycline
were compared to bacteria grown in LB Miller broth with no oxytetracycline, using a
previously described hybridization protocol (Ducey et al, 2005). Briefly, RNA was
extracted using the modified hot-phenol method described above. The RNA
concentration was determined using Ribogreen® (Molecular Probes) and the absence of
DNA was confirmed by PCR. Using equivalent amounts (16 µg) of RNA from each
sample, the RNA was reverse transcribed to cDNA in the presence of aminoallyl
nucleotides. The RNA was mixed with 8 µl of 5x 1st strand buffer, 2 µl of DTT (0.1M),
10 µg random primer and DEPC water to 34.35 µl, and then incubated sequentially at
65°C for 5 minutes and 42°C for 5 minutes. Thereafter, the nucleotide and reverse
transcriptase reagents were mixed (1 µl dGTP, dATP and dCTP at 20 mM, 1.3 µl of
dTTP at 5 mM, 1.35 µl of aminoallyl-dUTP at 10 mM and 2 µl of Superscript® II
(Invitrogen)) and 5.55µl was added to the RNA mixture and allowed to incubate at 42°C
for 2 hours. The reaction was then stopped by base hydrolysis of the RNA using 4 µl of
50 mM EDTA and 2 µl of 10N NaOH and incubated at 65°C for 20 minutes. This
reaction was then neutralized with 4 µl of 5M acetic acid. To remove the free amine, the
reactants and products were filtered through a Microcon® 30 filter with 450 µl of water.
The filtrate was centrifuged at 9800g for 8 minutes, repeated 4 times. The Microcon® 30
filter was then inverted in a new tube and the sample collected by centrifuging at 16,000g
for 1 minute. It was then dried down in a speed vacuum to 9 µl.
At this time, the aminoallyl labeled cDNA was coupled to the Cy dye. Each
sample was resuspended in 10 µl of 0.1 µl of Na-carbonate. Monofunctional NHS-ester
Cy3 and Cy5 solutions were made by resuspending one vial of dye in 65 µl water-free
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DMSO. Ten microliters of Cy3 solution was added to the control (no oxytetracycline)
and 10 µl of Cy5 solution was added to the treated sample (2 µg/ml oxytetracycline).
These were then incubated for 1 hour at room temperature in the dark. Following
incubation, 35 µl of 100 mM NaOAc (pH 5.2) was added and uncoupled dye was
removed using a Qiagen® PCR purification kit. Buffer PB (500 µl) was added to the
mixture and all applied to the column and centrifuged. The column was then washed
with 750 µl of PE buffer 4 times. The sample was then eluted with 40 µl of water at pH
7.4.
To prepare the samples for hybridization, the now Cy - labeled probes were dried
down in a speed vacuum, resuspended in 23.25 µl of water and mixed together. The
following were added individually and mixed by pipetting between each addition: 2.5 µl
10 µg/ml salmon sperm DNA, 25 µl formamide, 25 µl 20x SSC and 1 µl 10% SDS. This
solution was then denatured at 99°C for 2 minutes, cooled to 42°C, then hybridized to the
slide.
The Combimatrix Custom Array® slides were washed with 100 µl of water at
65°C for 10 minutes. They were then prepared with a prehybridization solution
containing 250 µl of 20x SSC, 250 µl formamide, 10 µl of 10% SDS, 10 mg BSA and
water to 1 ml and incubated for 30 minutes at 42°C. Once the prehybridization was
complete, the solution was removed and the hybridization solution containing the labeled
probes was added to the slide and the slide incubated at 42°C overnight (~16 hours). The
hybridization solution was then removed and the slide washed with 2x SSC and 0.1%
SDS for 5 minutes at 42°C. The next wash was with 0.1x SSC and 0.1% SDS for 10
minutes at room temperature. This was followed by 5 washes with 0.1x SSC for 1
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minute each and two final washes with 2x PBS for 5 minutes each. The imaging solution
was added following the final wash and the array scanned using a Perkin Elmer Scan
Array® microarray scanner. The slides were scanned at 532 nm (Cy3) and 635 nm (Cy5)
wavelengths at 5µm resolution and 70, 80 and 90% gain. GenePix Pro 3.0.5 software
(Axon Instruments, Foster City, California) was used to evaluate the fluorescence
intensity of each spot. Spot registration was optimized manually and exported to
OriginPro 7 software (OriginLab Corporation, Northampton, Massachusetts). The spots
were then filtered, and those with bad signals excluded. The background was subtracted
and the fluorescence intensity in each wavelength log2 transformed and normalized using
MIDAS software (The Institute for Genomic Research; http://www.tigr.org/software/).
To analyze the microarray data, the significant analysis of microarray (SAM) algorithm
was used. This Microsoft Excel software add in is available at http://www-
stat.stanford.edu/~tibs/SAM/.
Results
Exposure to salicylate resulted in a concentration-dependent increase in the level
of expression of marA (Figure 3). The growth curves from this experiment indicated that
increasing concentrations of salicylate did not effect the growth of Salmonella, as the
mid-log phase was reached at ~4 hours in all concentrations (Figure 4). When exposed to
oxytetracycline, concentrations lower than the MIC produced no statistically significant
difference in the level of expression of marA. However, at the MIC of 2 µg/ml, a large,
statistically significant difference in expression was observed (Figure 5).
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The next set of experiments were designed to examine more closely the
expression of marA in relation to a wider range of initial oxytetracycline concentrations
and to correlate these results with any changes in drug concentration occurring as a
function of incubation time. Growth curves of Salmonella cultured in 0, 1, 2, and 4
µg/ml of oxytetracycline in LB broth indicated significant concentration – dependent
slowing in growth (Figure 6). However, even though growth rate was decreased at the 2
and 4 µg/ml concentrations, the bacteria still remained viable and entered an exponential
phase of growth after a prolonged initial stationary phase. The 4 µg/ml samples (twice
the MIC of 2 µg/ml) reached mid-log phase at around 52 hours. The corresponding
bioassay results indicated that oxytetracycline had decreased (probably as a result of
degradation) to a concentration of ~1.6 µg/ml at this time (Figure 7). The 2 µg/ml
samples reached mid-log phase at about 40 hours with a corresponding oxytetracycline
concentration of 0.6 µg/ml. Interestingly, the highest level of marA expression occurred
at 2 µg/ml oxytetracycline, and not at the higher 4 µg/ml concentration, even though the
latter had decreased to a level below the MIC by the time the mid-log sample was
collected (Figure 8).
Experiments conducted to assess the expression of marA as a function of
incubation time confirmed that growth of the bacterium is closely correlated with
oxytetracycline concentration and that the microorganism does not enter an exponential
growth phase before the concentration of drug degrades to a level below MIC (Figure 9).
Analysis of marA expression by RT-qPCR indicated that the level of expression was
highest at mid-log phase (~36 hours) when Salmonella Typhimurium was incubated in an
initial oxytetracycline concentration of 2 µg/ml oxytetracycline versus the relative lack of
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gene expression in mid-log phase (~4 hours) bacteria incubated without oxytetracycline
(Figure 10). The increased expression of marA in samples exposed to oxytetracycline
was not only correlated with increased resistance to oxytetracycline, as confirmed by the
higher MIC (8 µg/ml) of the bacterium after incubation versus the pre-incubation
inoculum (2 µg/ml), but the MIC values for several other chemically unrelated
antibacterial agents (chloramphenicol, ampicillin and gentamicin) were also higher in the
incubated samples (Table 1).
Incubation conditions that produced the highest level of marA expression were
selected for microarray analysis: Bacteria were cultured in 2 µg/ml oxytetracycline and
samples were collected at mid-log phase of growth and RNA was extracted. The RNA
isolated at that time point was compared with RNA isolated from samples grown in LB
broth with no oxytetracycline. The goal of the microarray was to identify genes affected
by up-regulation of the MarA protein as well as unrelated genes affected by
oxytetracycline exposure. In contrast to the real-time PCR experiments, microarray
analysis indicated no significant change in the mar regulon or the efflux genes and porin
genes usually associated with mar regulon function. However, approximately 72 other
genes were up-regulated, but only a few of them are considered to be antibacterial
resistance genes (Table 2). Many of the genes that were up-regulated encode for
ribosomal subunit proteins. Approximately 125 genes were down-regulated. While
many of these genes encode for putative outer and inner membrane proteins, none of
these currently are recognized as porin proteins (Table 3). Many of the proteins that were
down regulated are involved in flagella production and assembly.
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Discussion
Many chemicals have been found to induce the mar system in Salmonella,
including salicylate (primary inducer), chloramphenicol, dinitrophenol, paraquat,
benzoate and bile acids (Randall et al, 2001b, 2002; Prouty et al, 2004). It has been
hypothesized that the mar system evolved to aid in the survival of enteric bacteria in the
hostile environment of the gastrointestinal tract, because expression of the system confers
resistance to bile acids (Prouty et al, 2004). While tetracycline has been found to induce
the mar system in E. coli, it has not been implicated in the induction of the system in
Salmonella (Randall et al, 2002). The present research demonstrated that the mar
regulon is in fact induced in Salmonella Typhimurium exposed to oxytetracycline, but
not to the same extent as in response to salicylate.
Concurrent induction of marA expression, and increase in the MIC value for
oxytetracycline, provides strong circumstantial evidence that marA expression is related
to antibacterial resistance. Indeed, concurrent increases in the MIC values for several
other chemically unrelated antibacterial agents is consistent with the induction of multi-
drug resistance mechanisms mediated by efflux pumps and porin proteins. In the cases of
chloramphenicol and gentamicin, the two-fold increases in MIC values were relatively
modest and were consistent with the functions of efflux pumps and porin proteins.
However, the MIC of ampicillin increased eight-fold, suggesting the involvement of
additional resistance mechanisms. It is probable that expression of the mar system may
promote acquisition of additional resistance capabilities (through gene mutations or
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transfer of resistance genes) by allowing higher numbers of bacteria to survive and
replicate (Randall et al, 2002, Chu et al, 2005). As demonstrated in the present study,
this is most likely to occur at concentrations similar to the MIC value, which would result
from dosage regimens that are not high enough to ensure elimination of the bacteria.
The observation that bacteria inoculated into broth containing oxytetracycline at
the MIC level not only express marA but also grow exponentially after a prolonged
stationary phase has very important implications for in vitro sensitivity testing.
Considering that such testing utilizes an 18-hour incubation period, which is of shorter
duration than the stationary phase observed in the present study, a sensitivity
determination based on the absence of growth at the MIC level may overestimate
susceptibility to an antibacterial agent. Indeed, the results of the present study suggest
that the MIC value may vary, depending on the duration of exposure to the antibacterial
agent and the expression status of resistance genes that may be induced by exposure to
the agent.
As stated before, approximately 125 genes were down regulated in the presence
of oxytetracycline, and approximately 72 genes were up regulated. Genes that were
noticeably absent from these lists include the mar genes, marR, marO, marA, marB and
marC. Also missing were the genes that encode for the acrAB efflux system and the
Omp porin proteins that are believed to be regulated by the mar regulon (Alekshun et al,
1999; Cohen et al, 1988). There are several possible explanations for this finding: The
sensitivity of the RT-qPCR system is much higher than that of the microarray system,
which may be one reason the changes seen with PCR are not seen with the microarray.
Another possibility is that the RNA was not extracted in large enough quantity or good
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enough quality to achieve the sensitivity needed to observe those changes. The genes
that were up regulated include several ribosomal subunit proteins, which may be related
to resistance to oxytetracycline. Oxytetracycline exerts its antibacterial effect by
inhibiting the binding of aminoacyl tRNA to the A site on the 30S ribosomal subunit,
thus inhibiting bacterial protein synthesis. Other proteins of interest include several outer
membrane proteins of unknown function that were up regulated: The putative S-
adenosylmethionine-dependant methyltansferase (STM3109) is involved in macrolide
resistance. Putative outer membrane protein (STM1819) is actually a starvation inducible
outer membrane lipoprotein that has been noted in previous experiments to be down-
regulated in the presence of antibiotic and possibly in response to mar, but was up-
regulated in the present experiment (Price et al, 2000). The major cold shock protein
(STM3649) up regulated here has been found to be involved in the stress response in
certain bacterial species (Katzif et al, 2003; Mangalappalli-Illathu et al, 2006). The
magnesium transport protein, MgtC (STM3764), is required for intramacrophage
replication as it allows for increased uptake of magnesium (Rang et al, 2007).
Tetracyclines bind magnesium to gain entry into the cell and for binding to the ribosomal
subunit, which may lead to low magnesium availability for bacterial cellular needs.
Thus, up-regulation of this gene would promote uptake of magnesium for cellular
processes and facilitate bacterial survival (Chopra et al, 2001). A few other proteins of
interest include the putative SAM-dependent methyltrasfease (STM4500) that is involved
in tellurite resistance and the starvation inducible inner membrane protein, PsiE
(STM4226), both of which were up regulated in the microarray.
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A number of the down-regulated genes are also of particular interest: Several are
putative outer membrane proteins and transport proteins of unknown function. The
majority of the down-regulated genes are involved in flagella production and assembly.
The decrease in production of the flagellar proteins has previously been reported as a
response to antimicrobials (Bader et al, 2003). Perhaps the flagellar proteins are down
regulated as a means to conserve amino acids in a stress environment, or perhaps they are
a liability because they facilitate host recognition of the bacterial cell.
The interest in oxytetracycline stems from the fear that the prophylactic and
metaphylactic use of antimicrobials in food animals may result in resistant infections in
humans (Angulo et al, 2004; Mlot, 2001; Fox, 2001). Oxytetracycline is an approved and
commonly used antibacterial in food animals, both prophylactically and
metaphylactically. Label indications include bacterial pneumonia (shipping fever), pink
eye, as well as any other susceptible infection (Liquimycin®LA200, Pfizer). The
implications of oxytetracycline causing mar induction are significant because it raises the
possibility that prophylactic use of oxytetracycline in food animals may result in
resistance not only to oxytetracycline but also to other antibacterial agents that are used
commonly to treat human infections, such as fluoroquinolones. While this research does
not indicate that oxytetracycline – induced mar expression led to increased resistance to
fluoroquinolones, based on the MIC data and the microarray data, resistance to several
other important antibacterial agents was induced and there is still need for concern that
drugs labeled for use in food animals may lead to resistant infections in humans.
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Figure 3. RT-qPCR results from initial salicylate experiments done in duplicate. Each
column represents the mean fold difference plus and minus the standard
deviation for each sample. This graph indicates an increase in marA
expression with exposure to increasing concentrations of salicylate.
Statistically significant changes are seen at the higher concentrations of 50
and 100 µg/ml (*).
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Figure 4. This growth curve indicates the change in OD600 of Salmonella Typhimurium
over time in increasing concentrations of salicylate (µg/ml). These results
represent one of two growth curves done in the presence of salicylate. The
increasing concentrations of salicylate do not affect the growth rate of
Salmonella.
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Figure 5. RT-qPCR results from oxytetracycline experiments in Salmonella
Typhimurium done in triplicate. This graph indicates a statistically significant
increase in expression of marA at 2 µg/ml (*). Columns represent the mean
fold difference plus and minus the standard deviation.
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Figure 6. Graph of the growth curve (OD 600) of Salmonella in increasing
concentrations of oxytetracycline (0, 1, 2, and 4 µg/ml). This represents one of
three replicates. In all replicates, the 4 µg/ml was significantly slower in
growth, but did grow given enough time.
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Figure 7. Graph showing the initial concentration of oxytetracycline versus the
concentration at mid-log phase of growth of Salmonella as determined by
bioassay. Each column represents the mean plus and minus standard
deviation of the concentration of oxytetracycline (µg/ml) at mid-log phase of
growth done in triplicate. Those samples started at 1 and 2 µg/ml reached
mid-log phase at just above 0.5 µg/ml. The sample started at 4 µg/ml reached
mid-log phase at around 1.5 µg/ml, a statistically significant difference(*).
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Figure 8. Graph depicting the RT-qPCR results of samples taken at mid-log phase in 0,
1, 2, and 4 µg/ml oxytetracycline. Each column represents the mean plus and
minus the standard deviation of the fold difference for marA expression for
that sample. Three biological replicates were done and two RT-qPCR
replicates for each biological sample were analyzed. This graph is a
compilation of all replicates, biological and RT-qPCR. A statistically
significant difference in expression can be seen at 2 and 4 µg/ml, but 2µg/ml
has a much higher fold difference in expression than 4µg/ml (*).
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Figure 9. Graph of oxytetracycline concentration and OD600 of Salmonella versus time
indicating that growth of Salmonella does not actually start until the
concentration of oxytetracycline falls below 1 µg/ml.
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Figure 10. Graph of the level of expression of marA in 2 µg/ml oxytetracycline at early,
mid and late log phase of the growth curve versus expression in LB without
oxytetracycline. Columns are mean difference plus and minus the standard
deviation for that sample. This data is from one of three biological
experiments with two RT-qPCR analyses done for each biological replicate.
Statistically significant differences can be seen at 20, 28 and 36 hours with the
highest fold difference at 36 hours, mid-log phase (*).
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Table 1. MIC values for Salmonella Typhimurium wild type versus oxytetracycline
induced. This data represents one of three replicates and all had similar
results. The most significant changes are seen in oxytetracycline,
chloramphenicol, ampicillin and gentamicin.
Antibiotic Wild Type Mar-Induced
Oxytetracycline 2 8
Erythromycin >16 >16
Ciprofloxacin <0.125 <0.125
Chloramphenicol 4 8
Ampicillin 2 16
Gentamicin 4 8
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Table 2. Genes up-regulated in the presence of oxytetracycline as determined by
microarray analysis. Those in bold are involved in antibiotic resistance.
UP
ribosomal subunit protein S20 50S ribosomal subunit protein L18
30S ribosomal subunit protein S2 50S ribosomal subunit protein L6
protein chain elongation factor EF-Ts 50S ribosomal subunit protein L5
putative RHS-like protein 30S ribosomal subunit protein S17
protohaeme IX farnesyltransferase 50S ribosomal subunit protein L29
cytochrome o ubiquinol oxidase subunit I 30S ribosomal subunit protein S3
Sec-independent protein secretion pathway component 50S ribosomal subunit protein L22
7,8-diaminopelargonic acid synthetase 30S ribosomal subunit protein S19
protein chain initiation factor IF-1 50S ribosomal subunit protein L2
putative inner membrane protein 50S ribosomal subunit protein L23
50S ribosomal subunit protein L32 50S ribosomal subunit protein L4
putative outer membrane protein 50S ribosomal subunit protein L3
putative outer membrane lipoprotein 30S ribosomal subunit protein S10
50S ribosomal subunit protein L20 30S ribosomal subunit protein S7
putative peptide transport protein 30S ribosomal subunit protein S12
putative outer membrane protein dehydroquinate synthase
50S ribosomal subunit protein L25 putative ribonucleoprotein related-protein
NADH dehydrogenase transcriptional repressor major cold shock protein
50S ribosomal subunit protein L19 50S ribosomal subunit protein L33
tRNA (guanine-7-)-methyltransferase Mg2+ transport protein
16S rRNA processing protein acetolactate synthase I large subunit
30S ribosomal subunit protein S16 small heat shock protein
putative cytoplasmic protein 50S ribosomal subunit protein L34
putative S-adenosylmethionine-dependent methyltransferase 50S ribosomal subunit protein L31
putative cytoplasmic protein preprotein translocase
50S ribosomal subunit protein L27 50 S ribosomal subunit protein L11
30S ribosomal subunit protein S9 50S ribosomal subunit protein L1
possible dehydrogenase putative inner membrane protein
factor-for-inversion stimulation protein 30S ribosomal subunit protein S6
50S ribosomal subunit protein L17 primosomal replication protein N
30S ribosomal subunit protein S11 30S ribosomal subunit protein S18
30S ribosomal subunit protein S13 50S ribosomal subunit protein L9
preprotein translocase putative SAM-dependent methyltransferase
50S ribosomal subunit protein L15 putative cytoplasmic protein
30S ribosomal subunit protein S5
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Table 3. Genes down-regulated in the presence of oxytetracycline as determined by
microarray analysis. Those in bold are involved in antibiotic resistance.
DOWN
putative cytoplasmic protein lysine decarboxylase 1
putrescine/ornithine antiporter secreted effector protein
ornithine decarboxylase isozyme transcriptional regulator
stress response DNA-binding protein invasion regulatory protein
putative minor tail protein putative cytoplasmic protein
anaerobic dimethyl sulfoxide reductase subunit A needle complex export protein
anaerobic dimethyl sulfoxide reductase subunit B needle complex assembly protein
pyruvate formate lyase I needle complex inner membrane lipoprotein
putative FlgK/FlgL export chaperone needle complex minor subunit
anti-FliA factor needle complex major subunit
flagella basal body P-ring formation protein precursor needle complex inner membrane protein
flagellar basal-body rod protein invasion protein regulatory protein
cell-proximal portion of basal-body rod invasion protein transcriptional activator
basal-body rod modification protein invasion protein precursor
flagellar hook protein protein tyrosine phosphatase/GTPase activating protein
cell-proximal portion of basal-body rod secretion chaparone
flagellar basal-body rod protein putative acyl carrier protein
flagellar L-ring protein precursor secreted effector protein
putative flagellar basal body protein translocation machinery component
flagellar biosynthetic protein translocation machinery component
flagellar hook-associated protein 1 translocation machinery component
flagellar hook-associated protein 3 secretion chaperone
MltA-interacting protein A needle complex export protein
putative periplasmic protein needle complex export protein
putative outer membrane protein needle complex export protein
transcriptional regulator needle length control protein
putative periplasmic transport protein needle complex assembly protein
methyl-accepting chemotaxis protein III needle complex secretion ATPase
mannose-specific enzyme IIAB secretion chaperone
mannose-specific enzyme IIC needle complex export protein
mannose-specific enzyme IID invasion protein
hypothetical protein outer membrane secretin precursor
chemotactic response protein invasion regulatory protein
chemotaxis regulator needle complex outer membrane lipoprotein precursor
methyl esterase glycine cleavage complex protein H
methyl accepting chemotaxis protein II fructose-bisphosphate aldolase
chemotaxis docking protein periplasmic L-asparaginase II
chemotaxis sensory histidine protein kinase putative methyl-accepting chemotaxis protein
chemotaxis protein putative cytoplasmic protein
flagellar motor proton conductor component putative methyl-accepting chemotaxis protein
putative periplasmic binding transport protein aerotaxis sensor receptor
putative FliA-regulator L-serine deaminase
sigma 28 pyruvate formate-lyase 4/2-ketobutyrate formate-lyase
lysine-N-methylase propionate kinase/acetate kinase II
flagellin L-threonine/L-serine permease
flagellar hook-associated protein 2 threonine dehydratase
flagellar protein phosphoenolpyruvate carboxykinase
possible FliD export chaperone methyl-accepting transmembrane citrate/phenol chemoreceptor
putative flagellar hook-basal body protein hypothetical protein
flagellar motor switch protein ketodeoxygluconokinase
flagellar assembly protein putative cytoplasmic protein
flagellar protein putative fructose-1,6-bisphosphate aldolase"
flagellar hook-length control protein triosephosphate isomerase
flagellar biosynthetic protein putative methyl-accepting chemotaxis protein
flagellar motor switch protein putative ABC exporter outer membrane component
flagellar biosynthetic protein putative inner membrane protein
polyhedral body protein putative cytoplasmic protein
periplasmic glycerophosphodiester phosphodiesterase putative regulatory protein
putative chemotaxis signal transduction protein putative DNA-binding protein
lysine/cadaverine transport protein methyl-accepting chemotaxis protein I
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CHAPTER 5: THE IN VIVO EFFECT OF OXYTETRACYCLINE ON EXPRESSION
OF THE SALMONELLA TYPHIMURIUM GENES, marA, cspA, mgtC, AND slp, IN
CATTLE.
Introduction
Multi-drug resistant bacteria, including non-typhoidal salmonelloses, are
responsible for increased morbidity and mortality of infections in humans and animals
(Threlfall, 2002; Molbak, 2005; Furuya et al, 2006). Of particular concern are the use of
antibacterial agents in food animals and the possibility that such use may cause the
emergence of resistant food-borne infections in humans (Angulo et al, 2004; Mlot, 2001;
Fox, 2001; Gomez et al, 1997). The current, FDA-sanctioned, approach to minimizing
this risk is to restrict the use of antimicrobial agents in food animals to those agents not
commonly used in humans, thus preserving the susceptibility of human pathogens to
other antibacterial agents used exclusively in humans (Molbak, 2005; Furuya et al, 2006).
However, the recent discovery of multidrug resistant mechanisms, such as those encoded
by the mar regulon, has raised concerns that this approach may not be prudent. As
demonstrated by the experiments described in Chapter 4, the mar system responds to the
presence of certain antimicrobial agents and chemicals by up-regulating synthesis of
MarA protein, which in turn up-regulates genes encoding for efflux systems and down-
regulates genes encoding for porin proteins, thus creating multi-drug resistance in
response to exposure to a single chemical (Alekshun et al, 1999a, 1997, Randall et al,
2002). Therefore, it is possible that exposure to antibacterial agents routinely used in
food animals, and not in humans, could lead to multi-drug resistance against a variety of
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chemically unrelated antibacterial agents, including those used only in humans. For
example, it may be possible, considering the involvement of the mar system, to cause
resistance to fluoroquinolones (restricted use in food animals) by exposure to
oxytetracycline (commonly used in food animals).
Quinolones represent a mechanistic group of antibacterial agents considered to be
one of only a few available drug classes appropriate for use against resistant infections,
including human salmonellosis. However, several recent outbreaks of salmonelloses in
humans have led to the discovery that while ciprofloxacin and nalidixic acid are
recognized to be drugs of choice for treating resistant Salmonella infections, they are no
longer effective in all cases, due to resistance. Fluoroquinolones are not available for
widespread prophylactic use in food animals in the United States, and yet resistant, food-
borne outbreaks have still occurred (Molbak, 2005; Hsueh et al, 2004; Zansky et al,
2002; Miko et al, 2005), thus suggesting that fluoroquinolone resistance in humans may
have been caused by use of different antibacterial agents in food animals and emergence
of multi-drug resistance.
The experiments described in Chapter 4 clearly demonstrated that exposure of
Salmonella Typhimurium to oxytetracycline induced the expression of the marA gene
and concurrently caused the development of multi-drug resistance to oxytetracycline and
several other chemically unrelated antibacterial agents. However, the role of the mar
regulon has not been studied in vivo and it is possible that exposure to oxytetracycline
may also affect the expression of marA-independent mechanisms that confer antibacterial
resistance. Therefore the goal of this study was to investigate the in vivo effect of
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oxytetracycline, at low and high doses, on marA expression as well as the expression of
any other genes that may be involved in oxytetracycline-induced multi-drug resistance.
Selection of genes, other than marA, that may be involved in oxytetracycline-
induced multi-drug resistance was guided by the results of the in vitro microarray
experiment described in Chapter 4. This experiment compared Salmonella Typhimurium
cultured in the absence of antibacterial agents with bacteria grown in broth with 2 ug/ml
oxytetracycline. The genes selected, cspA, mgtC, and slp, encode for a cold shock
protein, a magnesium transport protein and a starvation-induced outer membrane protein,
respectively.
The cold shock protein, CspA, has been found to increase resistance in several
bacteria, including Staphylococcus aureus and Salmonella enterica serovar Enteritidis
(Katzif et al, 2003; Mangalappalli-Illathu et al, 2006). The magnesium transport protein,
MgtC, is up regulated to support intracellular growth of bacteria, and in conditions of low
magnesium concentration (Rang et al, 2007). Oxytetracycline chelates magnesium to
gain entry into the bacterial cell as well as to bind to the ribosomal subunit. Magnesium
bound to oxytetracycline would not be available to the bacterium, unless mgtC is up-
regulated (Chopra et al, 2001). The starvation-induced outer membrane protein, Slp, has
been found to down-regulate in the presence of antibiotic and possibly in response to mar
expression (Price et al, 2000). However, our experiments demonstrated an increase in the
expression of this protein in response to oxytetracycline in vitro.
The in vivo model selected for this study was a bovine soft-tissue infection model,
established by inoculation of tissue chambers implanted subcutaneously in cattle (Clarke
et al, 1989, 1996). These chambers form an abscess like environment, where immune
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cells and drugs can enter and exit, but the infectious agent, in this case Salmonella, is
primarily confined to the chamber. Implantation of several chambers in each animal
allowed collection of multiple samples over a period of several days, thus minimizing the
number of animals needed. Furthermore, Salmonella bacteria could be harvested without
being contaminated with other enteric bacterial organisms.
Materials and Methods
Animals
Nine cross-bred calves were obtained from local sources. Shortly after arrival,
calves were confirmed to be healthy by physical examination and housed in outdoor pens.
They were fed free choice prairie grass hay and a commercial grain ration containing
14% protein. Health was monitored daily by assessing rumen fill, attitude, respiratory
function, and rectal temperature. The study protocol was approved by the Oklahoma
State University Institutional Animal Care Use Committee and the Biosafety Committee.
At the conclusion of each experiment, cattle were euthanized by pentobarbital overdose,
after initial sedation with IM xylazine. Chambers were removed and incinerated, and
cattle were disposed of according to approved biosafety protocols.
Implantation of tissue chambers
Tissue chambers were constructed of Delrin, a non-reactive thermoplastic
(Delrin®, EI du Pont de Nemours & Co, Wilmington, DE), and the top of each chamber
was covered with a medical-grade, silicon-dacron elastomer (Technical Products,
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Decatur, GA) to allow percutaneous collection of samples. Chambers measured 4.6 cm
internal diameter, 5.2 cm outer diameter, and 1.5 cm in depth. Chambers were
assembled, autoclaved and surgically implanted, as previously described (Clarke et al,
1989, 1996). Each calf had 2 tissue chambers implanted subcutaneously in each
paralumbar fossa for a total of 4 chambers per calf. Implanted chambers were allowed to
heal for several months and then checked for sterility by culturing an aspirate of chamber
fluid aerobically and anaerobically; all chambers determined to be infected were removed
prior to inoculation.
Preparation of inocula
Chambers were inoculated with an ATCC strain of Salmonella enterica serovar
Typhimurium LT2 (ATCC 700720). The minimum inhibitory concentration for
oxytetracycline against this isolate was determined to be 2.0 µg/ml. Salmonella
Typhimurium isolates were initially streaked for purity and then cultured for 5 hours
(mid-log phase) in LB Miller broth. Thereafter, the culture was centrifuged at 9800g for
15 minutes to pellet the cells, the supernatant was removed and the cells were
resuspended in phosphate buffered saline (PBS) to the concentration of bacteria required
for each experiment.
Experimental design
Cattle were moved to an indoor BSL-2 facility 2 days prior to inoculation to allow
time acclimatization. Chambers were sampled prior to inoculation to confirm sterility.
Chambers were then inoculated with Salmonella Typhimurium and tissue chamber fluid
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was collected periodically, according to the protocol for each experiment. Samples were
analyzed for determination of bacterial concentration (CFU/ml) and oxytetracycline
activity (in treated cattle), and RNA was extracted for RT-qPCR analysis of gene
expression.
The first experiment involved two calves (#52 and #33). The Salmonella
Typhimurium inoculum was diluted in PBS to a concentration of 6.25 x 106 CFU/ml and
1 ml was injected into each of the chambers. Chambers were sampled immediately
following inoculation, and then at 5 and 24 hours post inoculation. Starting 24 hours after
inoculation, one calf (#52) was administered 2 IV doses (20 mg/kg) of oxytetracycline
(LA200®, Pfizer), 24 hours apart. The other calf (#33) received one IM dose of
oxytetracycline (10 mg/kg) 24 hours after chamber inoculation. Samples were collected
every 12 hours for 10 days and analyzed for bacterial and oxytetracycline concentration.
Samples for RNA extraction were collected immediately prior to oxytetracycline
treatment and at 2, 5 and 10 days post-treatment.
In the second experiment, all chambers in 2 calves (#34 and #67) were inoculated
with a higher concentration of bacteria, 2.75 x 1010 CFU/ml in 1 ml, to provide more
mRNA for extraction and analysis. Samples for determination of bacterial concentration
were collected at 5 and 24 hours post inoculation. At 24 hours post inoculation, cattle
were treated with oxytetracycline: one calf (#67) received 20 mg/kg, IV, twice, 24 hours
apart; and the other calf (#34) received one IM dose of 10 mg/kg. Samples were then
collected on days 1, 2, 3, 4, 5, 7, 11 and 17 post-treatment and analyzed for bacterial and
oxytetracycline concentration. Samples for RNA extraction were collected before
administration of oxytetracycline and on days 1, 4, 7, 11 and 17, post treatment.
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The third experiment was conducted using five calves (#78, #3, #18, #20, and
#11). Each chamber in all calves was inoculated with 1 ml containing ~6 x 109 CFU of
Salmonella Typhimurium. Samples were collected immediately post inoculation and at
1, 2, 3, 4, 5, 6, 7, 8, and 9 days after inoculation for determination of bacterial
concentration. Twenty-four hours after inoculation, chambers were sampled for RNA
extraction. Cattle were then treated with oxytetracycline: Two cattle (#78 and #3)
received one IM injection of 10 mg/kg; two cattle (#18 and #20) received two IV doses of
20 mg/kg, 24 hours apart and one animal (#11) served as a negative control and received
no oxytetracycline. Samples collected at 1, 2, 3, 4, 5, 6, 7, and 8 days after the initial
treatment day were analyzed for the concentration of oxytetracycline. Samples were also
collected at 1, 2, 3, 4, 6, and 8 days after initial treatment for bacterial RNA extraction.
Sample analysis
Samples (0.5 ml) for determination of CFU/ml were immediately placed on ice
and analyzed using spot plate counts on LB Miller agar plates, after serial dilution in
PBS.
Oxytetracycline concentrations in samples (0.5 ml) were determined by bioassay,
using the methods described in Chapter 4.
RNA extraction in preparation for analysis of gene expression proved to be very
challenging due to the low numbers of bacteria within the chambers, particularly in
animals receiving higher doses of oxytetracycline, and the interference of eukaryotic
cells. Several protocols were tested on in vitro cultures to determine the most effective
method of extraction. Protocols tested included the Qiagen RNeasy® (Valencia, CA) and
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Ambion Ribopure® (Austin, TX) kits, a hot phenol protocol designed for intracellular
pathogens and a modified hot phenol method used in the in vitro experiments described
in Chapter 4, respectively. Initially, Salmonella was grown in vitro to a concentration of
~1x108 CFU/ml and diluted to 107, 106, 105, 104, and 103 CFU/ml. These dilutions were
then extracted using all of the protocols listed above. Based on these results, the hot
phenol and the modified hot phenol methods were selected for further testing using tissue
chamber fluid infected with Salmonella Typhimurium. Ultimately, the modified hot
phenol method (Naikare et al, 2006; Stintzi et al, 2003) was determined to yield the best
results and was selected for extraction of in vivo samples (10 ml) collected from tissue
chambers.
Assessment of gene expression
The RT-qPCR primer and probe sets were designed using Primer Express®
software. Eurogentec® one-step RT-qPCR MasterMix Plus kits were used, following the
supplied protocol. All the RT-qPCR reactions were performed on an ABI Prism 7700
Sequence detector®. A comparative analysis was used, assuming the 16s gene
(normalizing gene) was maximally expressed in all conditions. The ddCt method was
used for data analysis to determine the fold differences in level of expression (Applied
Biosystems, 2001). Standard deviations were used to determine statistical significance
between fold differences.
The primary purpose of these experiments was to study the effect oxytetracycline
on marA expression. Therefore, in the first and second cattle experiments, only marA
was studied due to the limited amount of RNA collected and extracted from the samples.
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Fortunately, the third experiment yielded much larger quantities of RNA due to
optimization of the experimental protocol. This success allowed investigation of several
other genes of interest, which were selected for further study based on the results of the in
vitro microarray data described in Chapter 4. These genes encode for the cold shock
protein (STM 3649), the magnesium transport protein (STM 3764), and the starvation
outer membrane protein (STM 1819).
Results
The first experiment served as a pilot study to optimize methods and procedures.
Figure 11 describes the changes in chamber fluid CFU/ml for Salmonella Typhimurium
in both the IV- and IM-treated cattle. While the concentration of bacteria in the
oxytetracycline IV-treated calf decreased dramatically to approximately 100 CFU/ml, the
infection was not sterilized and bacterial numbers eventually rebounded to a final
concentration very similar to that seen in the IM-treated calf. The bacterial numbers
produced by the inoculation employed in this first experiment were insufficient to support
expression analysis of more than one gene, thus necessitating a change in protocol in
subsequent experiments. Bioassay of oxytetracycline activity (Figure 12) indicated a
large difference in oxytetracycline concentrations between the IV- and IM-treated calves.
These results explain the sudden decrease in the number of bacterial cells at
approximately the same time as the second spike in oxytetracycline concentration after
administration of the 20 mg/kg dose. The IM treatment produced a much lower peak
concentration of approximately 1 ug/ml, which was lower than the MIC for the
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inoculation isolate (2 µg/ml). The IV treated calf had a peak concentration of
approximately 6 µg/ml. The RT-qPCR results indicated a slight increase in expression of
marA in the IM-treated animal at 24 hours post-treatment, followed by decreasing
expression during the rest of the sampling period. Intravenous administration of the
higher 20 mg/kg dose caused a slight increase in marA expression at 24 hours post-
treatment, but the expression of marA was much higher at 10 days post-treatment (Figure
13). This pattern of expression mirrored the changes in oxytetracycline concentration as
a function of time.
The second experiment yielded similar results to those of the first. Numbers of
bacteria in tissue chambers decreased significantly in both the IV- and IM-treated animals
(Figure 14). The CFU/ml counts in the IV-treated animal appeared to rebound a little
faster, but by the end of the experiment the bacterial numbers in IV- and IM-treated tissue
chambers were similar. In addition, the oxytetracycline bioassay results were also
similar. The large peak in concentration for the IV calf was slightly higher than that for
the IV calf in the first experiment, reaching a peak concentration of 6.7µg/ml. The IM-
treated calf had a peak concentration of approximately 0.5µg/ml, about half that observed
in the first experiment (Figure 15). Samples collected for analysis of gene expression
were used to optimize methods for RNA extraction. These efforts enabled development
and selection of procedures for analysis of multiple genes in the third experiment, but
unfortunately it was not possible to perform RT-qPCR analysis of gene expression in this
experiment.
In the third experiment, two animals received the low IM dose, two animals
received the high IV dose and one animal served as an untreated control. Bacterial
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counts in tissue chamber fluid decreased in all cattle, including in the non-treated control
animal, thus demonstrating the effect of host defenses in the absence of antibacterial
agent (Figure 16). However, all treated cattle still had lower numbers of bacteria than the
non-treated control, and those cattle treated with the higher IV dose of oxytetracycline
had lower bacterial counts than those treated with the lower IM dose. Although bacterial
counts decreased, none of the infections were sterilized. The concentration of
oxytetracycline was significantly higher in the IV-treated cattle than in the IM-treated
cattle, as expected, although there was more variation than expected between the two IV-
treated cattle (approximately 16 µg/ml and 7 µg/ml). Neither of the IM-treated cattle ever
had a concentration above 2 µg/ml (the MIC). In both the IV- and IM-treated cattle, the
concentration of oxytetracycline continued to decrease gradually through the duration of
the experiment, and even reached undetectable levels in 3 of the 4 treated cattle (Figure
17).
For this third experiment, 20 ml of infected tissue chamber fluid sample was
extracted from each of the chambers for RNA analysis. The expression of marA was
significantly increased in both the IV- and IM-treated cattle, but the fold difference in
expression was much higher in the IV-treated cattle. In both the IM- and IV-treated
cattle, one set of samples indicated an increase in expression early in the experiment
followed by a decline, while the other set did not increase until later in the experiment.
This appears to be a variation associated with the marA gene, as the other genes studied
were more consistent between the two animals for each treatment (Figures 18 and 19).
Figures 20 and 21 describe the expression of the cold shock protein, which is increased in
the IV-treated animals and more so than in the IM-treated animals, with the exception of
68
the spike in expression in #78 on day 10. The fold difference in expression of this gene
was not nearly as high as that observed in the marA data. The magnesium transport
protein also had increased expression in the treated cattle (Figures 22 and 23). In this
case, the one IM–treated animal, #78, had the highest level of expression. With the
exception of this animal, the IV-treated animals had higher levels of expression, but again
not as high as the marA gene. The starvation outer membrane protein was expressed the
most in the animal that did not receive any oxytetracycline (Figures 24 and 25); none of
the other animals had any significant increase in expression.
Discussion
Oxytetracycline is not the treatment of choice for salmonelloses in humans and its
use as a prophylactic and therapeutic agent in cattle is believed, therefore, to pose little
risk with regard to promoting development of resistance of human infections to
therapeutic drugs, such as the fluoroquinolones. However, the results of the in vitro
experiments described in Chapter 4 indicated that exposure of Salmonella Typhimurium
to oxytetracycline at concentrations close to the MIC value caused the expression of
marA to increase, and that this response was correlated with increased resistance to
oxytetracycline as well as several other chemically unrelated antibacterial agents. This
observation was consistent with the hypothesis that oxytetracycline can induce expression
of the mar regulon, which regulates expression of a number of multi-drug resistant
mechanisms, including efflux pumps and outer membrane porin proteins, and that
activity of these systems can confer resistance to antibacterial agents unrelated to the
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original inducer. In an effort to test this hypothesis further, it was necessary to confirm
that exposure to oxytetracycline in vivo also caused expression of the marA gene. In
addition, it was recognized that other genes may also be involved, as suggested by the in
vitro microarray data, which implicated cspA, mgtC, and slp.
The in vitro studies described in Chapter 4 indicated that marA expression was
correlated with oxytetracycline concentration, and that the highest expression occurred at
concentrations that were 25 – 50% of the MIC. This result was potentially important
because it suggested that the tissue concentrations produced by prophylactic and
therapeutic dosage regimens may be relevant to the likelihood of resistant strains
emerging. Therefore, different doses of oxytetracycline were employed in the in vivo
experiments to investigate the effect of drug dose and resultant tissue concentrations. In
this respect, the tissue chamber model is ideally suited to the study objectives because it
provides a means of measuring the concentration of antibacterial agent in the same in
vivo location occupied by the bacterial pathogen. Close examination of the
oxytetracycline concentration-time plots (Figure 17) and the marA expression data reveal
similar correlations between drug concentration and gene expression: Significantly
increased gene expression was observed only in oxytetracycline-treated animals.
Furthermore, animals receiving the lower IM dose demonstrated expression levels that
were much lower than those produced by the higher IV dose. However, it was apparent
also that excessively high concentration had a negative impact on expression, as indicated
by the difference between responses induced by the IV dose in the two experimental
animals in the third experiment. Significant expression in calf number 18 occurred only
after the very high peak drug concentration had declined, whereas the response in calf
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number 20, which had a lower peak oxytetracycline concentration, occurred more
quickly. Interestingly, marA expression was increased substantially in the presence of
oxytetracycline that was several-fold higher than the MIC value, thus indicating a higher
resistance of the isolate in vivo than was observed in vitro. Specifically, marA was up-
regulated when the oxytetracycline concentration was between 6 and 8 µg/ml, but at
concentrations above this marA was expressed at the same level as it was in the absence
of antibacterial agent. At concentrations below the 6 – 8 µg/ml level, the expression of
marA was quite variable between animals. It can be assumed from previous studies
(Gambino et al, 1993) as well as the in vitro MIC data reported in Chapter 4, that tissue
chamber bacteria surviving oxytetracycline at concentrations higher than the MIC are
probably also multi-drug resistant.
The gene (cspA) that encodes for the cold shock protein is believed to be involved
in adaptation of Salmonella to different stressors, including exposure to antibacterial
agents (Katzif et al, 2003; Mangalappalli-Illathu et al, 2006). Expression analysis of this
gene in vivo indicated that even in the animal receiving no treatment (#11), the
expression of cspA was altered, although not to the same degree as in the treated animals.
The IV treated animals once again had a higher fold change in expression than the IM
animals, reflecting the higher concentration of oxytetracycline and its effect on the
bacterial cells. With the exception of one animal that received the lower IM dose, there
appeared to be an optimal concentration necessary for cspA expression, as confirmed by
the relative responses in the two animals receiving the high IV dose: the calf with the
lower tissue concentration had higher levels of expression that the calf with the higher
tissue concentrations.
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The magnesium transport protein (mgtC) data indicates an increase in expression
in both the IM- and IV-treated animals early in the experiment, and a subsequent
decrease as the concentration of oxytetracycline declines. The expression response was
greatest in the IM treated cattle, again suggesting a drug concentration dependency
whereby the optimal concentration is neither too high nor too low. Apparently, the mgtC
gene is sensitive to lower concentrations of oxytetracycline, which may be related to the
role of MgtC in promoting intracellular survival of Salmonella (Rang et al, 2007) and the
relative protection from effective drug concentration that the intracellular locations
provide.
The starvation outer membrane protein (slp) is normally down regulated in the
presence of antibiotic (Price et al, 2000). However, in the in vitro microarray study, this
protein was up-regulated in the presence of oxytetracycline. In contrast, the data for the
in vivo study are more consistent with previously published reports in that there was no
evidence of increased gene expression, but gene expression was significantly higher in
non-treated animals versus those that received oxytetracycline.
This preliminary in vivo study of marA, cspA, mgtC and slp, indicates that not
only are the bacteria responding to the host environment, but also to the concentration of
oxytetracycline, as expected. The up-regulation of marA is of particular concern because
this protein alone is responsible for conferring multi-drug resistance by the activation and
inhibition of so many other proteins (Gambino et al, 1993, Alekshun et al, 1997),
including those involved in efflux pumps and porins. While the present study did not
directly address the possibility of oxytetracycline exposure in food animals causing the
emergence of multi-drug resistant Salmonella Typhimurium infections in humans, it is
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clear that the up-regulation of marA and differential expression of cspA, mgtC and slp
provides strong mechanistic evidence that this is possible. Furthermore, the results
confirming the correlation between oxytetracycline concentration and gene expression
indicate that emergence of resistance may be related to drug dose, thus raising the
probability that doses could be optimized to minimize emergence of resistance.
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Figure 11. Growth curve depicting the changes in CFU concentration of Salmonella in
the tissue chamber for the first cattle experiment. The oxytetracycline IV
treated animal has a much lower bacterial cell count at 72 hours post infection,
but rebounds and does not ever reach zero.
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Figure 12. Graph depicting the bioassay results for the first cattle experiment. The IV
treated animal had a peak concentration of 6 µg/ml after the initial dose, and a
second peak at 5.5 µg/ml. Following the second peak the concentration
dropped to zero by 120 hours. The IM treated calf had an initial concentration
around 1 µg/ml that then dropped to zero by 96 hours.
75
0
20
40
60
80
100
120
140
160
180
pre 33 33-24h 33-10d pre 52 52-24h 52-10d
Cattle number-time post drug administration
fo
ld
di
ffe
re
n
ce
Figure 13. Graph depicting the RT-qPCR results for the first cattle experiment. Calf
number 33 received one IM dose of oxytetracycline and had a slight increase
in expression of marA at 24 hours post-drug administration and then it
declined again by 10 days. Calf number 52 received two IV doses of
oxytetracycline. The expression of marA was slightly elevated at 24 hours
post-treatment and had an even greater increase in expression at 10 days post
treatment.
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Figure 14. Growth curve depicting bacterial cell numbers for Salmonella for the second
cattle experiment. This experiment started with a higher inoculum and
therefore did not reach as low of a nadir as the first experiment. Again, the
number of bacterial cells did not reach zero.
77
0
1
2
3
4
5
6
7
8
0 48 96 144 192 240 288 336 384 432
hours post administration
O
x
yt
et
ra
cy
cl
in
e
co
n
ce
n
tr
a
tio
n
34 IM
67 IV
Figure 15. Graph depicting oxytetracycline bioassay results for the second cattle
experiment. Number 67 had two IV treatments of oxytetracycline 24 hours
apart, the peak for this calf was almost 7 µg/ml of oxytetracycline following
the second treatment. The concentration then drops sharply to zero by 168
hours. The IM treated calf (#34) had an initial concentration of less than 1
µg/ml and it stayed about this concentration until it dropped to zero at 168
hours.
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Figure 16. Growth curve depicting bacterial cell numbers for Salmonella in the third
cattle experiment. In all animals the bacterial cell counts dropped, including
calf #11 which received no treatment (NT). The IV oxytetracycline - treated
cattle (#18 and #20) had the lowest bacterial cell counts, but by 216 hours the
bacterial cell counts for all cattle had reached about the same level of
1.00E+03.
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Figure 17. Graph depicting the bioassay results for the third cattle experiment. Calf #20
had a similar pattern to the previously IV treated cattle, starting around 7
µg/ml and declining to zero by 168 hours. The IM treated cattle also had
similar patterns to those seen in the previous experiments. Calf #18 had a
peak concentration of almost 16 µg/ml, a very high concentration that did not
reach zero by 192 hours.
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Figure 18. Expression of marA gene in IV oxytetracycline - treated cattle. Calf #20
started with a high level of expression of marA that gradually decreased as the
concentration decreased. Calf #18 had a low concentration that peaked at
around 96 hours, decreased at 144 hours and then increased again at 216
hours. The no-treatment control (NT) had no significant change in
expression. The columns represent the mean fold difference plus and minus
the standard deviation based on the RT-qPCR analyses done in duplicate.
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Figure 19. Expression of marA in oxytetracycline IM treated cattle. Both of the IM
treated cattle had an increase in expression of marA at 24 hours post treatment
compared to the animal receiving no treatment (#11 NT). However, at 48 and
96 hours, #3 continued to have increased expression while #78 had returned to
the same as #11. Columns represent mean fold difference plus and minus the
standard deviation based on the RT-qPCR analyses done in duplicate.
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Figure 20. Expression of STM 3469 the cold shock protein in IV oxytetracycline -
treated cattle. Calf #20 had a much larger increase in expression that #18 for
the IV treated animals even though #18 had much higher concentration of
oxytetracycline. Calf #11 (no treatment) had a significant increase in
expression at 96 hours. Columns represent mean fold difference plus and
minus the standard deviation based on the RT-qPCR analyses done in
duplicate.
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Figure 21. Expression of cold shock protein (STM 3469) in IM oxytetracycline - treated
cattle. Calf #3 had no increase in expression of the cold shock protein
throughout the experiment. Calf #78 had an increase in expression only at
216 hours. Columns represent mean fold difference plus and minus the
standard deviation based on the RT-qPCR analyses done in duplicate.
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Figure 22. Expression of STM 3764 Magnesium transport protein in IV oxytetracycline -
treated cattle. Calf #20 and calf #18 had increases in expression of the
magnesium transport protein at 24 and 48 hours compared to the calf
receiving no treatment. After 48 hours, no difference was seen. Columns
represent mean fold difference plus and minus the standard deviation based on
the RT-qPCR analyses done in duplicate.
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Figure 23. Expression of magnesium transport protein (STM 3764) in IM
oxytetracycline - treated cattle. Calf #78 had a significant increase at 24 hours
that gradually decreased throughout the experiment. Calf #3 had a slight
increase at 24 hours, but not to the same degree as #78. Columns represent
mean fold difference plus and minus the standard deviation based on the RT-
qPCR analyses done in duplicate.
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Figure 24. Expression of STM 1819 Starvation Outer Membrane Protein in IV
oxytetracycline - treated animals. The highest change in expression for this
protein was seen in the #11 calf that received no treatment. This spike was
seen at 24 hours post treatment for the treated calves. Columns represent mean
fold difference plus and minus the standard deviation based on the RT-qPCR
analyses done in duplicate.
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Figure 25. Expression of starvation outer membrane protein (STM 1819) in IM
oxytetracycline-treated cattle. The highest level of expression is again seen in
the animal that received no treatment at all, #11, at 24 hours. Columns
represent mean fold difference plus and minus the standard deviation based on
the RT-qPCR analyses done in duplicate.
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CHAPTER 6: SUMMARY AND CONCLUSIONS
The growing concern of antimicrobial resistance has led to changes in the
regulations for antibacterial drug use in both human and animal medicine. The current
strategy for preventing the spread of resistance includes utilizing antibacterial agents with
spectra of activity that narrowly target the specific etiological pathogens as opposed to
using broad-spectrum drugs, as well as limiting the use of antibacterial agents in food
animal medicine to those not used in human medicine. This approach is predicated on
the understanding that exposure to one antibacterial agent will not lead to emergence of
resistance to other mechanistic classes of agents. However, this strategy does not take
into account the involvement of multi-drug resistance mechanisms, such as the mar
regulon, that may be induced by exposure to one agent and then confer phenotypic
resistance to many different chemical classes of antibacterial agents.
The discovery of the mar system in Salmonella brought into question the wisdom
of current regulatory measures (Sulavik et al, 1997). Salmonella is a common food-
borne pathogen of humans that frequently requires the use of antibiotic for treatment
(CDC 2005). Recent outbreaks of multi-drug resistant Salmonella infections have placed
the use of antimicrobials in food animals under even more scrutiny (Hseuh et al, 2004;
Zansky et al, 2002). Isolates resistant to the fluoroquinolones are of particular concern as
this mechanistic group is considered the last line of defense for treatment of Salmonella
in humans (Molbak, 2005).
In summary, the results of the present study indicated that expression of marA in
Salmonella Typhimurium could be induced by oxytetracycline, in contrast to the
89
conclusions of a previously published report (Randall et al, 2002). Furthermore,
exposure of Salmonella Typhimurium to oxytetracycline produces a concentration-
dependent response whereby expression is maximized when concentrations are neither
too high nor too low. Depending on whether such exposure occurs in an in vitro or in
vivo environment, maximal expression generally occurs at concentrations 0.25 – 0.5
times or 3 – 4 times the MIC value, respectively. This observation suggests that dosage
regimens for oxytetracycline in cattle could be optimized to minimize expression of the
mar regulon and any resultant emergence of resistance. Finally, oxytetracycline-induced
increase in marA expression was correlated with increased resistance of oxytetracycline
and several other mechanistically unrelated antibacterial agents in vitro and survival of
the bacterium in vivo, thus presenting strong circumstantial evidence in support of the
underlying project hypothesis; that the prevalence of bacteria that are antibiotic resistant
due to the expression of multidrug resistance systems increases when cattle are
administered prophylactic antibiotics and that the wide substrate specificity of these
systems confers resistance not only to antibiotics used prophylactically but also to
antibiotics used therapeutically in cattle and human consumers of contaminated beef
products. Although the results of the in vitro study failed to identify development of
fluoroquinolone resistance in response to oxytetracycline exposure, previously published
research (Cohen et al, 1989) reported that use of tetracycline antibiotics did lead to
fluoroquinolone resistance in E. coli, so there is still a possibility that this could occur in
Salmonella under different experimental conditions.
Obviously, further studies are needed to confirm that oxytetracycline-induced
expression of marA is directly responsible for development of multi-drug resistance, and
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that this resistance can be transferred to consumers of beef products. The factors relevant
to this possibility clearly are very complex, as is illustrated by the possible involvement
of the three other genes (cspA, mgtC and slp) identified in the in vitro study and
investigated in the in vivo study.
An unexpected finding of the current research project is that in vitro incubation of
Salmonella Typhimurium in liquid media containing oxytetracycline at or higher than the
MIC inhibits growth for at least 18 hours, but that with longer incubation the bacterium
will replicate exponentially, and that this delayed growth is correlated with an increase in
resistance. This observation has important implications with respect to the interpretation
of in vitro sensitivity data (these usually are derived from 18-hour cultures) and may
explain why bacterial isolates classified as being intermediately susceptible may not
respond favorably to therapeutic doses designed only to achieve tissue concentrations that
barely exceed the MIC.
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